Malignant neoplasm of endocrine gland

C3_ENDOCRINE

endocrine neoplasm: A benign or malignant neoplasm arising from the epithelial cells of an endocrine organ. Representative examples include pituitary gland adenoma, pituitary gland carcinoma, thyroid gland carcinoma, carcinoid tumor, and neuroendocrine carcinoma.

Suggest a new description

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions None	519972
3. Check pre-conditions, main-only, mode, registry filters None 0 out of 7 registries used, show all original rules.	0
4. Check minimum number of events None	0
5. Include endpoints C3_THYROID_GLAND C3_ADRENAL_GLAND C3_ENDOCRINE_NAS	2915
6. Filter based on genotype QC (FinnGen only)	2816

Control definitions (FinnGen only)

Control exclude: C3_CANCER, C3_CANCER_WIDE

Extra metadata

Level in the ICD hierarchy: 2
First used in FinnGen datafreeze: DF4

NAME	C3_ENDOCRINE
CONTROL_EXCLUDE	C3_CANCER\|C3_CANCER_WIDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE	C3_THYROID_GLAND\|C3_ADRENAL_GLAND\|C3_ENDOCRINE_NAS
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Malignant neoplasm of endocrine gland based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

No data for upset plot.

No data for upset table.

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	2816	2038	778
Unadjusted period prevalence (%)	0.62	0.72	0.36
Median age at first event (years)	51.56	48.95	58.42

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
2914: Matched controls
29140

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

106

Kela drug reimbursment

Hypoparathyroidism

78.4

317.9

170

A11CC03

ATC

alfacalcidol; systemic

15.3

312.6

282

202

130

Kela drug reimbursment

Malignant tumour

+∞

307.7

407

PJD41

NOMESCO Finland

Excision of cervical lymph nodes

60.0

307.7

222

C73.99

ICD-10 Finland

Malignant tumor of the thyroid gland (thyroid gland), other or unspecified histology

+∞

307.7

334

ZX114

NOMESCO Finland

Intramuscular

48.6

307.7

453

110

JN5PN

NOMESCO Finland

Isotope imaging of secondary neoplasms of thyroid origin

+∞

307.7

667

EP1AE

NOMESCO Finland

Neck ultrasound examination

47.8

307.7

1380

538

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

5.5

307.7

1718

6064

H02AB02

ATC

dexamethasone; systemic

22.9

307.7

313

152

C73.92

ICD-10 Finland

Follicular carcinoma of the thyroid gland

3480.7

307.7

322

C73.91

ICD-10 Finland

Papillary carcinoma of the thyroid gland (thyroid gland)

+∞

307.7

2125

BAA40

NOMESCO Finland

Unilateral lobectomy of thyroid gland

30.1

307.7

646

273

A04AA02

ATC

granisetron; systemic, transdermal

181.6

307.7

171

PJ3AT

NOMESCO Finland

Cytology of lymphnode with ultrasound guidance

95.1

307.7

187

H03AA01

ATC

levothyroxine sodium; systemic

47.6

307.7

2647

5021

BA3AT

NOMESCO Finland

Cytology of thyroid with ultrasound quidance

34.6

307.7

391

130

E89.01

ICD-10 Finland

Postsurgical hypothyroidism

75.8

307.7

940

182

104

Kela drug reimbursment

Thyroid insufficiency

55.9

307.7

2039

1167

E89.2

ICD-10 Finland

Postprocedural hypoparathyroidism

73.2

307.7

198

8260/3-C73.9

ICD-O-3

Papillary adenocarcinoma, NOS, of thyroid gland

+∞

307.7

2024

C73.90

ICD-10 Finland

Malignant tumor of the thyroid gland (thyroid gland) without histology

+∞

307.7

371

C73

ICD-10 Finland

Malignant neoplasm of thyroid gland

+∞

307.7

433

D44.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Thyroid gland

98.8

307.7

745

101

XX7CT

NOMESCO Finland

Radioiodine therapy of thydoid tissue

168.1

307.7

796

J38.0

ICD-10 Finland

Paralysis of vocal cords and larynx

24.0

307.7

324

151

BAA60

NOMESCO Finland

Total thyroidectomy

121.9

307.7

1522

259

4CJ01, ,

NOMESCO Finland

+∞

307.7

308

E04.2

ICD-10 Finland

Nontoxic multinodular goitre

10.1

307.7

449

518

JN5AQ

NOMESCO Finland

SPECT of thyroid metastasis with low-dose CT

+∞

307.7

334

ZX012

NOMESCO Finland

Radiotherapy with large shaped fields - isocentric therapy

151.4

289.2

144

E89.09

ICD-10 Finland

Postprocedural hypothyroidism, other or several procedures

78.5

265.6

142

WF002

NOMESCO Finland

Radical radiotherapy

60.1

256.1

143

1930A

ICD-9 Finland

Malignant neoplasm of thyroid gland[CARCINOMA PAPILLARE THYREOIDEAE]

+∞

237.8

225

8330/3-C73.9

ICD-O-3

Follicular carcinoma, NOS, of thyroid gland

+∞

236.8

224

PJD71

NOMESCO Finland

Extended sparing excision of cervical lymph nodes

+∞

230.3

218

BA1NN

NOMESCO Finland

I-131 dose capsel measurement

+∞

230.3

218

Z51.88

ICD-10 Finland

Other specified medical care

12.6

223.0

224

191

115

Kela drug reimbursment

Breast cancer

+∞

214.3

203

E04.1

ICD-10 Finland

Nontoxic single thyroid nodule

11.6

213.5

227

211

WX408

NOMESCO Finland

General anesthesy, balanced

3.5

209.8

1058

4122

BA1AE

NOMESCO Finland

Thyroiid ultrasound examination

12.4

208.3

211

182

C44.31

ICD-10 Finland

Basocellular carcinoma of the skin on another or unspecified part of the face

38.2

196.0

121

D34

ICD-10 Finland

Benign neoplasm of thyroid gland

24.5

193.5

138

T71

ICPC

Malignant neoplasm thyroid

+∞

190.8

181

WX402

NOMESCO Finland

General anaesthesia

3.4

183.8

855

3132

PJA12

NOMESCO Finland

Sentinel node biopsy

380.2

180.6

180

XX3DW

NOMESCO Finland

Time consuming IT work

5.9

170.6

330

618

JN4BD

NOMESCO Finland

Extensive body CT

6.4

169.3

298

509

EP1DG

NOMESCO Finland

Very extensive examination of soft tissue of neck with high intesity magnet

27.8

169.1

115

2506

FHL

Thyroidectomy

294.4

164.5

166

WX404

NOMESCO Finland

Intravenous generell anesthesy

3.3

163.8

819

3109

E04.9

ICD-10 Finland

Nontoxic goitre, unspecified

8.1

163.7

227

299

E83.51

ICD-10 Finland

Hypocalcemia

25.8

163.1

114

WZC00

NOMESCO Finland

Treatment plan or consultation

2.9

162.8

1225

5847

A11CC02

ATC

dihydrotachysterol; oral

41.8

160.9

EP1CG

NOMESCO Finland

Extensive MRI examination of soft tissue of neck with high intesity magnet

18.8

160.6

128

19399

ICD-8 Finland

Malignant neoplasm of thyroid gland

+∞

154.6

147

D44.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Adrenal gland

15.1

150.0

134

ZXE10

NOMESCO Finland

More than one and less than three hours

2.7

143.0

1294

6686

R22.1

ICD-10 Finland

Localized swelling, mass and lump, neck

6.3

142.0

253

436

WF049

NOMESCO Finland

Radiotherapy of metastasis

487.6

141.6

140

8341/3-C73.9

ICD-O-3

Papillary microcarcinoma of thyroid gland

+∞

138.7

132

C79.8

ICD-10 Finland

Secondary malignant neoplasm of other specified sites

+∞

138.7

132

PJD81

NOMESCO Finland

Excision of lymph nodes from upper part of neck

1385.2

136.6

132

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

8.0

136.3

191

254

C50.41

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor

+∞

131.2

125

A12AA04

ATC

calcium carbonate; oral

11.8

130.9

135

119

ZXE20

NOMESCO Finland

More than three and less than five hours

3.5

127.2

518

1710

A03FA01

ATC

metoclopramide; systemic, rectal

3.2

126.7

623

2307

XW1AT

NOMESCO Finland

Biopsy from other organ close to skin with ultrasound quidance

24.5

123.8

EP2AT

NOMESCO Finland

Neck soft tissue cytology with ultrasound guidance

47.8

119.7

JN4AD

NOMESCO Finland

Body CT examination

5.0

118.8

273

592

HAB40

NOMESCO Finland

Wedge excision of mammary gland

17.5

115.5

Z51.5

ICD-10 Finland

Palliative care

6.7

115.0

189

299

JN6AD

NOMESCO Finland

CT of torso and neck

21.9

114.3

L03AA02

ATC

filgrastim; parenteral

64.4

114.0

C61

ICD-10 Finland

Malignant neoplasm of prostate

1141.7

113.4

110

8340/3-C73.9

ICD-O-3

Papillary carcinoma, follicular variant of thyroid gland

+∞

111.2

106

TPH07

NOMESCO Finland

Cathetrisation of artery

3.6

111.0

406

1244

A04AA01

ATC

ondansetron; systemic, rectal

5.7

109.6

212

394

C739, ,

ICD-10 Finland

+∞

108.0

103

WF003

NOMESCO Finland

Adjuvant radiotherapy

542.3

106.4

105

C78.0

ICD-10 Finland

Secondary malignant neoplasm of lung

+∞

105.9

101

YX9AD

NOMESCO Finland

Other CT eamination for dose design of radiotherapy

60.2

105.5

8140/3-C61.9

ICD-O-3

Adenocarcinoma, NOS, of prostate gland

+∞

103.8

8500/3-C50.9

ICD-O-3

Infiltrating duct carcinoma, NOS, of breast, NOS

+∞

103.8

L02BG04

ATC

letrozole; oral

8.4

103.3

137

170

BCA31

NOMESCO Finland

Endoscopic unilateral adrenalectomy

23.7

102.9

8090/3-C44.9

ICD-O-3

Basal cell carcinoma, NOS, of skin, NOS

+∞

102.7

L03AA13

ATC

pegfilgrastim; parenteral

349.1

101.8

102

HA1AA

NOMESCO Finland

X-ray mammography

5.2

101.5

218

445

WB113

NOMESCO Finland

Multiple adjuvant cytostatic therapy

980.5

97.6

2505

FHL

Bilateral resection (also used if total removal has been performed on the other side)

16.6

96.2

QAE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in head or neck

5.0

93.9

214

459

HA1AE

NOMESCO Finland

Ultrasound examination of mammary glands

5.3

92.2

192

381

WZC30

NOMESCO Finland

Teaching

2.9

91.9

489

1868

UDQ12

NOMESCO Finland

Flexible laryngoscopy

3.9

91.5

294

821

HAC20

NOMESCO Finland

Total mastectomy

137.2

87.5

PJD52

NOMESCO Finland

Block dissection of axillary lymph nodes

+∞

86.9

GD6AD

NOMESCO Finland

CT of chest and neck

38.5

86.0

L02BA01

ATC

tamoxifen; oral

118.7

85.4

WB223

NOMESCO Finland

Demanding adjuvant hormone therapy of malignancy

+∞

84.8

GD1AD

NOMESCO Finland

Thorax CT examination

4.4

83.8

221

533

WD125

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

218.8

82.8

WD105

NOMESCO Finland

Cystostatic therapy of methastized malignancy

129.6

82.4

HA003

NOMESCO Finland

Radiotherapy after partial ablation of mammary gland

820.9

81.9

YA1AD

NOMESCO Finland

CT examination of head and neck for dose design of radiotherapy

47.8

80.2

117

Kela drug reimbursment

Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue

7.7

80.0

113

151

D41.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Kidney

9.8

79.5

NK6AN

NOMESCO Finland

Total body bone isotope imaging

38.3

79.4

C77.0

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Lymph nodes of head, face and neck

778.7

77.7

XX6XT

NOMESCO Finland

Other intravascular therapy with radiological guidance

22.4

74.8

C79.5

ICD-10 Finland

Secondary malignant neoplasm of bone and bone marrow

+∞

74.3

WW200

NOMESCO Finland

Immunization

5.6

73.4

144

270

ZXD10

NOMESCO Finland

Scheduled procedure

2.0

72.8

1202

7454

JN4CD

NOMESCO Finland

Very extensive body CT

8.5

72.1

114

JN5DR

NOMESCO Finland

PET-CT of upper body metabolism

25.4

71.4

PJD91

NOMESCO Finland

Excision of lymph nodes in neck, 1 to 2 areas in total

704.9

70.4

WB103

NOMESCO Finland

Simple adjuvant cytostatic therapy

704.9

70.4

A04AA55

ATC

palonosetron, combinations; systemic

+∞

70.1

E03.89

ICD-10 Finland

Other specified hypothyroidism

3.8

68.9

220

609

EN1BD

NOMESCO Finland

Very extensive CT examination of mouth and soft tissues of neck

10.7

68.5

C73.94

ICD-10 Finland

Medullary thyroid carcinoma (thyroid)

+∞

66.9

YG1BD

NOMESCO Finland

Extensive CT examination of thorax for dose design of radiotherapy

663.0

66.2

C50.99

ICD-10 Finland

Breast, unspecified

663.0

66.2

C74.0

ICD-10 Finland

Malignant neoplasm: Cortex of adrenal gland

+∞

65.9

HA6AA

NOMESCO Finland

Extra corporeal mammography of operated mammary gland

10.8

63.8

C64.88

ICD-10 Finland

Other malignant neoplasm of kidney, except renal pelvis

+∞

63.8

XX9AQ

NOMESCO Finland

Supplementary SPECT-CT or additional scan

+∞

63.8

116

Kela drug reimbursment

Prostate cancer

+∞

63.8

ZXE30

NOMESCO Finland

More than five and less than seven hours

4.4

63.6

165

392

WX704

NOMESCO Finland

Intubation

3.0

63.4

302

1074

BBA70

NOMESCO Finland

Implantation or transplantation of parathyroid gland

27.3

62.9

WF004

NOMESCO Finland

Palliative radiotherapy

621.1

62.0

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

4.1

61.5

178

459

L01BC06

ATC

capecitabine; oral

+∞

58.5

T86

ICPC

Hypothyroidism/myxoedema

3.4

58.4

219

674

BBA30

NOMESCO Finland

Excision of lesion of parathyroid gland

7.0

57.7

131

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.9

57.7

1278

8567

JN5SN, ,

NOMESCO Finland

+∞

57.5

WX302

NOMESCO Finland

Thoracal epidural anesthesy

4.9

57.3

128

269

WB203

NOMESCO Finland

Simple adjuvant hormone therapy of malignancy

+∞

56.4

THW99

NOMESCO Finland

Other minor procedure in surgery of mammary gland

23.1

56.4

ZX070

NOMESCO Finland

Intensity modified radiotherapy

147.9

55.0

C74.1

ICD-10 Finland

Malignant neoplasm: Medulla of adrenal gland

+∞

53.3

E04.0

ICD-10 Finland

Nontoxic diffuse goitre

8.3

53.1

ZX090

NOMESCO Finland

Other technic of radiotherapy

86.1

53.1

EN1AD

NOMESCO Finland

CT examination of mouth and soft tissues of neck

9.2

52.6

A12AA06

ATC

calcium lactate gluconate; oral

96.9

52.0

ZXA10

NOMESCO Finland

Bilateral

2.1

51.5

605

3246

C74.9

ICD-10 Finland

Malignant neoplasm: Adrenal gland, unspecified

+∞

50.1

DQE10

NOMESCO Finland

Injection of foreign material into vocal cord

16.6

48.8

N02AA05

ATC

oxycodone; systemic

2.3

48.2

418

1983

Z31.5

ICD-10 Finland

Genetic counselling

3.4

47.5

182

567

WD505

NOMESCO Finland

Simple enzyme inhibitor or similar therapy of methastized malignancy

+∞

47.0

H02AB09

ATC

hydrocortisone; systemic

4.6

46.8

112

249

C44.51

ICD-10 Finland

Basocellular carcinoma of the skin on the torso

18.7

46.6

C50.21

ICD-10 Finland

Malignant tumor of the upper inner quadrant of the mammary gland,ductal tumor

+∞

46.0

C78.7

ICD-10 Finland

Secondary malignant neoplasm of liver and intrahepatic bile duct

+∞

46.0

8090/3-C44.3

ICD-O-3

Basal cell carcinoma, NOS, of skin of other and unspecified parts of face

+∞

44.9

E21.09

ICD-10 Finland

Other primary hyperparathyroidism

5.0

44.1

201

E27.5

ICD-10 Finland

Adrenomedullary hyperfunction

228.4

44.0

BAA99

NOMESCO Finland

Other operation on thyroid gland

155.7

43.9

PJA10

NOMESCO Finland

Exploration of lymph nodes

11.7

43.9

Z85.8

ICD-10 Finland

Personal history of malignant neoplasms of other organs and systems

+∞

43.9

C73.93

ICD-10 Finland

Anaplastic thyroid carcinoma (thyroid)

+∞

43.9

HA4AT

NOMESCO Finland

Labeling mammary gland pathology with ultrasound guidance

9.4

43.7

C50

ICD-10 Finland

Malignant neoplasm of breast

434.0

43.3

ZX080

NOMESCO Finland

Image guided radiotherapy

218.1

42.0

BCA30

NOMESCO Finland

Unilateral adrenalectomy

148.9

41.9

PJ5AN

NOMESCO Finland

Localisation of sentinell lymphnode with isotope imaging

+∞

41.8

HA1AT

NOMESCO Finland

Biopsy of mammary glands with ultrasound guidance

7.8

41.7

R59.0

ICD-10 Finland

Localized enlarged lymph nodes

4.2

41.7

112

273

ZXA05

NOMESCO Finland

Left side

1.9

41.4

701

4226

2504

FHL

Unilateral resection or enucleation

8.0

41.4

YG1AD

NOMESCO Finland

CT examination of thorax for dose design of radiotherapy

413.3

41.2

B01AB05

ATC

enoxaparin; parenteral

1.8

40.8

831

5298

C50.40

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, no histological veryfication

+∞

40.7

8290/3-C73.9

ICD-O-3

Oxyphilic adenocarcinoma of thyroid gland

+∞

40.7

8700/3-C74.9

ICD-O-3

Pheochromocytoma, NOS, of adrenal gland, NOS

+∞

40.7

ZXE00

NOMESCO Finland

One hour or less

1.7

40.1

1108

7693

BAA20

NOMESCO Finland

Unilateral partial excision of thyroid gland

13.9

40.0

WW500

NOMESCO Finland

Blood transfusion

4.8

39.8

195

O99.2

ICD-10 Finland

Endocrine, nutritional and metabolic diseases complicating pregnancy, childbirth and the puerperium

5.2

39.7

161

C50.42

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, lobular tumor

+∞

39.7

Y77

ICPC

Malignant neoplasm prostate

392.7

39.2

A79

ICPC

Malignancy NOS

392.7

39.2

TPH04

NOMESCO Finland

Cathetrisation of vein

1.9

38.9

587

3403

EP1AE, ,

SPAT

4.6

38.8

207

C50.90

ICD-10 Finland

Malignant tumor in other or unspecified location in mammary gland without histology

+∞

38.6

YA1BD

NOMESCO Finland

Extensive CT examination of head and neck for dose design of radiotherapy

57.1

38.4

A04AD12

ATC

aprepitant; systemic

135.2

37.8

198

Kela drug reimbursment

Sorafenib

+∞

37.6

XW000

NOMESCO Finland

Bone marrow biopsy

4.0

36.9

107

276

8345/3-C73.9

ICD-O-3

Medullary thyroid carcinoma of thyroid gland

+∞

35.5

PJD51

NOMESCO Finland

Block dissection of cervical lymph nodes

351.4

35.0

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

2.0

34.9

452

2480

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

4.5

34.7

197

8370/3-C74.0

ICD-O-3

Adrenal cortical carcinoma of cortex of adrenal gland

+∞

34.4

8520/3-C50.9

ICD-O-3

Lobular carcinoma, NOS, of breast, NOS

+∞

34.4

HA1TE

NOMESCO Finland

Supplementary or limited ultrasound examination of mammary glands

10.4

34.2

N02BE01

ATC

paracetamol; systemic, rectal

2.0

33.7

2563

22810

8510/3-C73.9

ICD-O-3

Medullary carcinoma, NOS, of thyroid gland

+∞

33.4

C83.31

ICD-10 Finland

Diffuse lymphoma with large B cells

+∞

33.4

C50.11

ICD-10 Finland

Malignant tumor of the central part of the mammary gland,ductal tumor

+∞

33.4

YL1BD

NOMESCO Finland

Extensive CT examination of pelvis for dose design of radiotherapy

+∞

33.4

HAB50

NOMESCO Finland

Partial excision of mammary gland with reconstructive operation

64.1

33.1

XZZ00

NOMESCO Finland

Active surveillance of a diagnosed cancer

330.8

32.9

C75.0

ICD-10 Finland

Malignant neoplasm: Parathyroid gland

330.8

32.9

BA1AQ

NOMESCO Finland

Thyroid SPECT with low dose CT

330.8

32.9

L02AE02

ATC

leuprorelin; implant, parenteral

5.6

32.9

112

B01AB10

ATC

tinzaparin; parenteral

2.4

32.4

244

1082

ZSB00

NOMESCO Finland

Procedure related to previous procedure classified in chapter B

43.9

31.8

L03AA14

ATC

lipegfilgrastim; parenteral

+∞

31.3

8700/3-C74.1

ICD-O-3

Pheochromocytoma, NOS, of medulla of adrenal gland

+∞

31.3

KE1AT

NOMESCO Finland

Biopsy of prostata with ultrasoudnguidance

5.3

31.0

122

NK6QA

NOMESCO Finland

Measurement of bone density from two or more locations with X-ray

2.7

30.5

170

653

ZXA00

NOMESCO Finland

Right side

1.7

30.5

722

4741

L01XX23

ATC

mitotane; oral

+∞

30.3

C50.81

ICD-10 Finland

Overall malignant tumor of the mammary gland, ductal tumor

+∞

30.3

XX9XW, ,

NOMESCO Finland

8.2

29.5

WX725

NOMESCO Finland

Noninvasive ventilation

2.6

29.4

172

677

JN4JR

NOMESCO Finland

Whole body extensive metabolic PET with CT

30.4

29.4

C79.30

ICD-10 Finland

Secondary malignant tumor of the cerebrum

+∞

29.2

3019

Kela drug reimbursment

Lenvatinib

+∞

29.2

A06AH03

ATC

naloxegol; oral

9.5

28.9

D35.0

ICD-10 Finland

Benign neoplasm: Adrenal gland

4.5

28.8

162

L02BG03

ATC

anastrozole; oral

81.0

28.8

X76

ICPC

Malignant neoplasm breast female

104.4

28.7

R59.1

ICD-10 Finland

Generalized enlarged lymph nodes

6.4

28.3

8500/3-C50.4

ICD-O-3

Infiltrating duct carcinoma, NOS, of upper-outer quadrant of breast

+∞

28.2

323

Kela drug reimbursment

Sorafenib

+∞

28.2

1508

Kela drug reimbursment

Lenvatinib

+∞

28.2

JN5AN

NOMESCO Finland

Total body isotope imaging

+∞

28.2

WD325

NOMESCO Finland

Demanding therapy of methastized malignancy with biomodifiers

55.6

28.2

PJD99

NOMESCO Finland

Excision of other lymph nodes

284.2

27.8

WD305

NOMESCO Finland

Simple therapy of methastized malignancy with biomodifiers

78.4

27.8

D05.1

ICD-10 Finland

Intraductal carcinoma in situ

78.4

27.8

E83.50

ICD-10 Finland

Hypercalcemia

5.4

27.8

104

WD115

NOMESCO Finland

Multiple cystostatic therapy of methastized malignancy

101.1

27.7

ZX112

NOMESCO Finland

Subcutaneous

6.7

27.7

8000/3-C73.9

ICD-O-3

Neoplasm, malignant of thyroid gland

+∞

27.1

XX1MN

NOMESCO Finland

Isotope examination with measurement

+∞

27.1

WD405

NOMESCO Finland

Simple antiboidy therapy of methastized malignancy

38.2

27.1

D48.5

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Skin

2.7

27.0

153

593

HAE10

NOMESCO Finland

Reconstruction of breast using graft or flap

62.6

27.0

E8901, C7391,

ICD-10 Finland

+∞

26.1

WB123

NOMESCO Finland

Demanding adjuvant cytostatic therapy

+∞

26.1

TQW20

NOMESCO Finland

Tatoe

60.6

26.0

L02BG06

ATC

exemestane; oral

262.9

25.7

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

2.8

25.5

130

477

UGC12

NOMESCO Finland

Flexible bronchoscopy

2.4

25.2

174

742

8020/3-C73.9

ICD-O-3

Carcinoma, undifferentiated, NOS, of thyroid gland

+∞

25.0

C50.91

ICD-10 Finland

Malignant tumor in another specified localization in ductal mammary gland

+∞

25.0

HA013

NOMESCO Finland

Radiotherapy after total ablation of mammary gland

+∞

25.0

S18

ICPC

Laceration/cut

1.5

25.0

1179

9021

KE3AT

NOMESCO Finland

Transrectal gold marker implantation in prostate under ultrasound guidance

252.3

24.7

XX2AT

NOMESCO Finland

Other injection with ultrasound examination

7.5

24.6

E05.0

ICD-10 Finland

Thyrotoxicosis with diffuse goitre

2.9

24.4

119

426

WD415

NOMESCO Finland

Demanding antibody therapy of methastized malignancy

48.8

24.3

BBA40

NOMESCO Finland

Subtotal parathyroidectomy

7.9

24.3

QBE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin of trunk

2.5

24.0

155

640

8310/3-C64.9

ICD-O-3

Clear cell adenocarcinoma, NOS, of kidney, NOS

+∞

24.0

C20.91

ICD-10 Finland

Malignant tumor of the rectum invasive carcinoma

+∞

24.0

L02BB03

ATC

bicalutamide; oral

+∞

24.0

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.9

23.8

323

1788

Z51.1

ICD-10 Finland

Chemotherapy session for neoplasm

126.1

23.6

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

2.1

23.0

241

1220

TPX10

NOMESCO Finland

Implantation of vascular injection port

3.9

22.9

174

8010/3-C75.0

ICD-O-3

Carcinoma, NOS, of parathyroid gland

+∞

22.9

Z85.3

ICD-10 Finland

Personal history of malignant neoplasm of breast

+∞

22.9

C54.11

ICD-10 Finland

Adenocarcinoma of the endometrium

+∞

22.9

Z01.8

ICD-10 Finland

Other specified special examinations

1.6

22.8

648

4412

D38.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung

5.2

22.7

D37.7

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Other digestive organs

4.3

22.6

141

SPAT1153

SPAT

Removal of sutures

1.5

22.6

805

5771

E03

ICD-10 Finland

Other hypothyroidism

2.1

22.5

214

1043

BB1BQ

NOMESCO Finland

Extensive scintigraphy of parathyroid gland, 2 isotopes, SPECT and low-dose CT

8.8

22.4

ZX120

NOMESCO Finland

Intravenous

2.2

22.2

194

915

ZX050

NOMESCO Finland

Stereotactic radiotherapy

52.4

22.1

24199

ICD-8 Finland

Non-toxic nodular goitre, Unspecified

5.0

22.1

C67.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of bladder

+∞

21.9

L01XE05

ATC

[U] sorafenib

+∞

21.9

1930B

ICD-9 Finland

Malignant neoplasm of thyroid gland[CARCINOMA FOLLICULARE THYREOIDEAE]

+∞

21.9

C50.51

ICD-10 Finland

Malignant tumor of the lower outer quadrant of the mammary gland, ductal tumor

+∞

21.9

WA039

NOMESCO Finland

Radiotherapy with free isotopes

221.6

21.6

R49.01

ICD-10 Finland

Functional dysphonia

2.7

21.4

119

457

PJ2AT

NOMESCO Finland

Biopsy of lymphnode with ultrasound guidance

23.3

21.3

HAE20

NOMESCO Finland

Reconstruction of areola and mamilla using graft or flap

50.4

21.1

1930X

ICD-9 Finland

Malignant neoplasm of thyroid gland[NEOPLASMA MALIGNUM THYREOIDEAE EI HISTOL VAHV]

+∞

20.9

8090/3-C44.5

ICD-O-3

Basal cell carcinoma, NOS, of skin of trunk

+∞

20.9

Z51.0

ICD-10 Finland

Radiotherapy session

77.4

20.7

JN1CG

NOMESCO Finland

Extensive MRI examination of upper part of abdomen with high intensity magnet

3.6

20.7

192

BWD00

NOMESCO Finland

Reoperation for deep haemorrhage in endocrine surgery

42.0

20.4

504

Kela drug reimbursment

Conditions requiring daily forced enteral nutrition

5.8

20.2

KAC10

NOMESCO Finland

Total nephrectomy with capsule

48.4

20.2

Z08.0

ICD-10 Finland

Follow-up examination after surgery for malignant neoplasm

23.5

19.9

PJ2AE

NOMESCO Finland

Lymphnode ultrasound examination

7.3

19.9

Z50.5

ICD-10 Finland

Speech therapy

4.1

19.9

133

R50.9

ICD-10 Finland

Fever, unspecified

1.8

19.9

348

2081

BA2MN

NOMESCO Finland

Thyroid radiation dose measurement during isotope therapy

+∞

19.8

C50.49

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, other or undeterminated histology

+∞

19.8

1AB01, ,

NOMESCO Finland

+∞

19.8

C50.82

ICD-10 Finland

Overall malignant tumor of the mammary gland, lobular tumor

+∞

19.8

GD6BD

NOMESCO Finland

Extensive CT of chest and neck

29.1

19.6

BA2AT

NOMESCO Finland

Biopsy of thyroid with ultrasound quidance

29.1

19.6

YL1AD

NOMESCO Finland

CT examination of pelvis for dose design of radiotherapy

201.3

19.6

E20.8

ICD-10 Finland

Other hypoparathyroidism

40.4

19.5

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.7

19.4

405

2541

JN4KR

NOMESCO Finland

Whole body very extensive metabolic PET with CT

26.2

19.1

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

2.0

18.9

208

1071

JDB10

NOMESCO Finland

Percutaneous gastrostomy

6.4

18.8

C50.4

ICD-10 Finland

Malignant neoplasm: Upper-outer quadrant of breast

+∞

18.8

KEC00

NOMESCO Finland

Retropubic radical prostatectomy

+∞

18.8

L01EX08

ATC

lenvatinib; oral

+∞

18.8

C34.12

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary adenocarcinoma

+∞

18.8

8010/3-C73.9

ICD-O-3

Carcinoma, NOS, of thyroid gland

+∞

18.8

WD135

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

+∞

18.8

YX9BD

NOMESCO Finland

Other extensive CT eamination for dose design of radiotherapy

70.3

18.7

C44.30

ICD-10 Finland

Malignant tumor of the skin on another or unspecified part of the face without histology

70.3

18.7

AA1CD

NOMESCO Finland

Very extensive CT of head and brain

4.8

18.7

R22.9

ICD-10 Finland

Localized swelling, mass and lump, unspecified

2.0

18.7

226

1202

WX400

NOMESCO Finland

Inhalation anesthesy

2.4

18.6

125

526

E20.9

ICD-10 Finland

Hypoparathyroidism, unspecified

23.8

18.6

E21.3

ICD-10 Finland

Hyperparathyroidism, unspecified

4.2

18.6

118

QX4AT

NOMESCO Finland

Ultrsound guided needle biopsy of skin

15.1

18.4

E05.2

ICD-10 Finland

Thyrotoxicosis with toxic multinodular goitre

3.9

18.4

141

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

3.0

18.3

281

R49.08

ICD-10 Finland

Other specified dysphonia

2.9

18.1

299

JN6BD

NOMESCO Finland

Extensive CT of torso and neck

14.4

18.1

R13

ICD-10 Finland

Dysphagia

2.0

18.0

200

1032

EP1BG

NOMESCO Finland

MRI examination of soft tissue of neck with high intesity magnet

7.6

17.8

GBB00

NOMESCO Finland

Tracheostomy

5.4

17.8

HAB99

NOMESCO Finland

Other partial excision of mammary gland

4.6

17.7

EP1DM

NOMESCO Finland

Very extensive MRI examination of soft tissue of neck with 3 Tesla magnet

67.0

17.7

XX9AN

NOMESCO Finland

Complementary isotope examination or additional picture

67.0

17.7

XX1XN

NOMESCO Finland

Other isotope examination

+∞

17.7

L01AX03

ATC

temozolomide; systemic

+∞

17.7

WD225

NOMESCO Finland

Demanding therapy of methastized malignancy with hormones

+∞

17.7

YG1CD

NOMESCO Finland

Very extensive CT examination of thorax for dose design of radiotherapy

+∞

17.7

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

2.4

17.6

125

540

C90.0

ICD-10 Finland

Multiple myeloma

181.1

17.5

C67.9

ICD-10 Finland

Malignant neoplasm: Bladder, unspecified

181.1

17.5

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

4.7

17.5

WX110

NOMESCO Finland

Infiltration anesthesia

1.4

17.3

1917

16746

Z08.7

ICD-10 Finland

Follow-up examination after combined treatment for malignant neoplasm

42.2

17.3

C44.32

ICD-10 Finland

Spinocellular carcinoma of the skin on another or unspecified part of the face

42.2

17.3

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

2.0

17.1

199

1045

R4130

NOMESCO Finland

Speech therapy

2.9

17.0

287

EP1CM

NOMESCO Finland

Extensive MRI examination of soft tissue of neck with 3 Tesla magnet

31.7

17.0

RL210, ,

NOMESCO Finland

6.6

17.0

R4110

NOMESCO Finland

Physiotherapy

1.5

16.8

659

4772

8140/3-C20.9

ICD-O-3

Adenocarcinoma, NOS, of rectum, NOS

+∞

16.7

WD205

NOMESCO Finland

Therapy of methastized malignancy with hormones

+∞

16.7

KEC01

NOMESCO Finland

Percutaneous endoscopic radical prostatectomy

+∞

16.7

166

Kela drug reimbursment

Dalteparin and tinzaparin (treatment for more than 6 months)

+∞

16.7

8312/3-C64.9

ICD-O-3

Renal cell carcinoma, NOS, of kidney, NOS

+∞

16.7

8500/2-C50.9

ICD-O-3

Intraductal carcinoma, noninfiltrating, NOS, of breast, NOS

+∞

16.7

9500/3-C74.1

ICD-O-3

Neuroblastoma, NOS, of medulla of adrenal gland

+∞

16.7

H03BB01

ATC

carbimazole; oral

2.2

16.6

139

644

J01DB01

ATC

cefalexin; oral

1.5

16.6

2270

20521

C44.41

ICD-10 Finland

Basocellular carcinoma of the skin of the scalp and neck

90.6

16.6

ZXE40

NOMESCO Finland

More than seven and less than nine hours

3.4

16.4

172

4701

FHL

Neck lymph node removal

30.2

16.1

Z80.8

ICD-10 Finland

Family history of malignant neoplasm of other organs or systems

21.1

16.0

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

2.1

15.9

158

783

H02AA02

ATC

fludrocortisone; oral

5.0

15.7

ZZF00

NOMESCO Finland

Graft of adipose tissue

6.9

15.7

8500/3-C50.2

ICD-O-3

Infiltrating duct carcinoma, NOS, of upper-inner quadrant of breast

+∞

15.6

8120/3-C67.9

ICD-O-3

Transitional cell carcinoma, NOS, of bladder, NOS

+∞

15.6

8097/3-C44.9

ICD-O-3

Basal cell carcinoma, nodular of skin, NOS

+∞

15.6

WB401

NOMESCO Finland

Simple antibody therapy of primary tumour

+∞

15.6

C78.6

ICD-10 Finland

Secondary malignant neoplasm of retroperitoneum and peritoneum

+∞

15.6

Z3226

NOMESCO Finland

Physiotherapist

1.6

15.4

453

3082

D11.0

ICD-10 Finland

Benign neoplasm: Parotid gland

3.4

15.2

166

NA7DG

NOMESCO Finland

Spine and spinal cord very extensive MRI examination with high intensity magnet

4.6

15.2

D25.9

ICD-10 Finland

Leiomyoma of uterus, unspecified

1.7

15.2

263

1565

E05.9

ICD-10 Finland

Thyrotoxicosis, unspecified

2.5

15.1

388

BAA30

NOMESCO Finland

Excision of thyroid isthmus

20.1

15.1

XKD00

NOMESCO Finland

Uroflowmetry

1.8

15.1

250

1468

UJC01

NOMESCO Finland

Scopy of lower throat

5.0

15.0

2419X

ICD-9 Finland

Non-toxic nodular goitre, Unspecified non-toxic nodular goitre

6.5

14.9

AA1BD

NOMESCO Finland

Extensive CT of head and brain

3.3

14.9

173

J01MA12

ATC

levofloxacin; systemic

1.6

14.8

413

2775

T85

ICPC

Hyperthyroidism/thyrotoxicosis

5.0

14.8

KCD02

NOMESCO Finland

Transurethral resection of bladder

11.3

14.8

UDQ02

NOMESCO Finland

Direct laryngoscopy

4.6

14.7

2410A

ICD-9 Finland

Non-toxic nodular goitre, Non-toxic uninodular goitre

13.3

14.7

2260A

ICD-9 Finland

Benign neoplasm of thyroid gland[NEOPLASMA BENIGNUM GLANDULAE THYREOIDEAE]

18.5

14.7

JJ2AT

NOMESCO Finland

Biopsy of liver with ultrasound guidance

3.4

14.6

155

8720/3-C44.9

ICD-O-3

Malignant melanoma, NOS, of skin, NOS

+∞

14.6

PJD64

NOMESCO Finland

Laparoscopic dissection of iliac lymph nodes

+∞

14.6

ZX013

NOMESCO Finland

Radiotherapy with large shaped fields - SSD therapy

+∞

14.6

C50.92

ICD-10 Finland

Malignant tumor in another specified localization in lobular gland, lobular tumor

+∞

14.6

C44.11

ICD-10 Finland

Basocellular carcinoma of the skin of the eyelids including the corner of the eye

+∞

14.6

L02BX02

ATC

degarelix; parenteral

+∞

14.6

8380/3-C54.1

ICD-O-3

Endometrioid adenocarcinoma, NOS, of endometrium

+∞

14.6

C20.90

ICD-10 Finland

Malignant tumor of the rectum without histology

80.5

14.6

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.7

14.5

259

1554

ZXC96

NOMESCO Finland

Robot assisted procedure

4.8

14.5

H01CB03

ATC

lanreotide; parenteral

150.7

14.5

C64

ICD-10 Finland

Malignant neoplasm of kidney, except renal pelvis

150.7

14.5

UJF32

NOMESCO Finland

Coloscopy

1.5

14.4

623

4584

XX2RW, ,

NOMESCO Finland

5.6

14.3

M05BX04

ATC

denosumab; parenteral

2.1

14.1

137

673

B01AB04

ATC

dalteparin; parenteral

2.2

14.0

124

588

A02BC02

ATC

pantoprazole; systemic

1.4

14.0

1792

15734

D70.82

ICD-10 Finland

Drug-induced neutropenia

10.9

14.0

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

1.8

13.9

203

1148

YA1VG

NOMESCO Finland

MRI examination of head and neck with high intesity magnet for dose design of radiotherapy

20.1

13.8

XX1AD

NOMESCO Finland

Other CT-examination

75.5

13.6

HAE05

NOMESCO Finland

Reconstruction of breast using soft tissue and prosthesis

75.5

13.6

C50.29

ICD-10 Finland

Malignant tumor of the upper inner quadrant of the mammary gland, other or undeterminated histology

+∞

13.5

L01XE29

ATC

[U] lenvatinib

+∞

13.5

C44.39

ICD-10 Finland

Malignant tumor of the skin on another or unspecified part of the face other or unspecified histology

+∞

13.5

L01CA04

ATC

vinorelbine; systemic

+∞

13.5

8680/3-C75.5

ICD-O-3

Paraganglioma, NOS, of aortic body and other paraganglia

+∞

13.5

C79.31

ICD-10 Finland

Secondary malignant tumor of the cerebellum

+∞

13.5

ZX095

NOMESCO Finland

Combined chemoradiotherapy

+∞

13.5

C50.12

ICD-10 Finland

Malignant tumor of the central part of the mammary gland,lobular tumor

+∞

13.5

D22.5

ICD-10 Finland

Melanocytic naevi of trunk

2.0

13.5

146

748

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

2.6

13.3

285

JN3AD

NOMESCO Finland

Abdominal CT examination

1.7

13.3

244

1475

WX602

NOMESCO Finland

Repeated or continuing anesthesia shots throug a catheter

1.9

13.3

184

1024

D25.1

ICD-10 Finland

Intramural leiomyoma of uterus

1.9

13.2

180

997

C91.1

ICD-10 Finland

Chronic lymphocytic leukaemia of B-cell type

40.3

13.1

WX720

NOMESCO Finland

Own respiration

2.1

13.0

128

633

HA1DG

NOMESCO Finland

Very extensive MRI examination of mammary gland with high intensity magnet

16.8

13.0

E21.0

ICD-10 Finland

Primary hyperparathyroidism

2.8

13.0

221

HA1CG

NOMESCO Finland

Extensive MRI examination of mammary gland with high intensity magnet

9.4

12.9

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

2.8

12.9

238

S04

ICPC

Lump/swelling localized

1.7

12.9

259

1603

ZZR00

NOMESCO Finland

Flap of skin

5.6

12.9

UDH02

NOMESCO Finland

Rhinopharyngoscopy

1.9

12.9

176

975

Z2221

NOMESCO Finland

Medical doctor

1.4

12.8

677

5152

T73

ICPC

Neoplasm endocrine other/unspecified

70.2

12.6

Z03.1

ICD-10 Finland

Observation for suspected malignant neoplasm

4.6

12.6

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.3

12.6

1065

8738

OAB38

NOMESCO Finland

Psychosocial guidance and counselling

32.2

12.6

C50.22

ICD-10 Finland

Malignant tumor of the upper inner quadrant of the mammary gland,lobular tumor

+∞

12.5

8070/3-C44.9

ICD-O-3

Squamous cell carcinoma, NOS, of skin, NOS

+∞

12.5

C34.32

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung adenocarcinoma

+∞

12.5

C18.71

ICD-10 Finland

Malignant tumor of the sigmoid invasive carcinoma

+∞

12.5

YJ2VG

NOMESCO Finland

MRI examination of pelvis with high intensity magnet for dose design of radiotherapy

+∞

12.5

C50.89

ICD-10 Finland

Overall malignant tumor of the mammary gland, other or undeterminated histology

+∞

12.5

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.6

12.4

336

2238

LCD04

NOMESCO Finland

Laparoscopic hysterectomy

2.1

12.3

116

564

ZYC06

NOMESCO Finland

Real-time text-based remote transaction

11.7

12.3

ENB50

NOMESCO Finland

Excision of cyst or fistula of thyroglossic duct

14.4

12.3

ZZQ00

NOMESCO Finland

Free microvascular graft of skin

37.7

12.2

QAE99

NOMESCO Finland

Other excision or repair surgery of skin and subcutaneous tissue in head and neck

3.3

12.2

133

E89.00

ICD-10 Finland

Postirradiation hypothyroidism

3.5

12.1

114

R49.8

ICD-10 Finland

Other and unspecified voice disturbances

3.3

12.0

139

QCE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in upper limb

2.9

12.0

192

A49.9

ICD-10 Finland

Bacterial infection, unspecified

1.7

11.8

201

1189

E04.8

ICD-10 Finland

Other specified nontoxic goitre

5.9

11.8

R23.8

ICD-10 Finland

Other and unspecified skin changes

1.5

11.8

443

3163

D37.6

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Liver, gallbladder and bile ducts

4.4

11.7

ZZR10

NOMESCO Finland

Flap of skin and muscle

16.5

11.7

308

Kela drug reimbursment

Alprostadil, sildenafil and combination product containing aviptadil and phentolamine

30.1

11.6

GDC01

NOMESCO Finland

Thoracoscopic lobectomy of lung

65.2

11.6

QAA05

NOMESCO Finland

Incision for biopsy of skin of head or neck

3.2

11.5

138

GD1CT

NOMESCO Finland

Biopsy of the lung with CT guidance

9.3

11.5

C77.1

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Intrathoracic lymph nodes

+∞

11.5

C85.9

ICD-10 Finland

Non-Hodgkin lymphoma, unspecified

+∞

11.5

YNB10

NOMESCO Finland

Collection of stem cells for transplant

+∞

11.5

YA1CD

NOMESCO Finland

Very extensive CT examination of head and neck for dose design of radiotherapy

+∞

11.5

C82.1

ICD-10 Finland

Follicular lymphoma grade II

+∞

11.5

8720/3-C44.5

ICD-O-3

Malignant melanoma, NOS, of skin of trunk

+∞

11.5

BC5AQ

NOMESCO Finland

Chromaffine tissue SPECT with low dose CT

+∞

11.5

153

Kela drug reimbursment

Lenalidomid

+∞

11.5

C83.9

ICD-10 Finland

Non-follicular (diffuse) lymphoma, unspecified

+∞

11.5

C43.72

ICD-10 Finland

Malignant melanoma of the lower extremity including the hip: 'superficial spreading' type

+∞

11.5

8140/3-C18.7

ICD-O-3

Adenocarcinoma, NOS, of sigmoid colon

+∞

11.5

C50.31

ICD-10 Finland

Malignant tumor of the lower inner quadrant of the mammary gland, ductal tumor

+∞

11.5

C18.01

ICD-10 Finland

Malignant tumor of the caecum invasive carcinoma

+∞

11.5

WF029

NOMESCO Finland

Radiotherapy of local residive tumor

120.5

11.4

WW300

NOMESCO Finland

Transfer of autologic stem cells

120.5

11.4

D44.9

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Endocrine gland, unspecified

120.5

11.4

128

Kela drug reimbursment

Cancers of female genital organs

120.5

11.4

UDC00

NOMESCO Finland

Ear microscopy

1.8

11.4

185

1080

J90

ICD-10 Finland

Pleural effusion, not elsewhere classified

2.8

11.3

193

GAB20

NOMESCO Finland

Median sternotomy

35.2

11.3

KA1AE

NOMESCO Finland

Kidney ultrasound examination

2.7

11.2

216

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

2.8

11.2

194

EP1AT

NOMESCO Finland

Punction of soft tissue of neck with ultrasound guidance

25.1

11.1

Z3231

NOMESCO Finland

Registered nurse

1.4

11.1

619

4738

JN1DG

NOMESCO Finland

Very extensive MRI examination of upper part of abdomen with high intensity magnet

3.2

11.1

141

QX3HE

NOMESCO Finland

Ultrsound examination of lesion close to skin

3.4

11.1

116

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.7

11.1

208

1265

ZXB10

NOMESCO Finland

Medial

5.7

11.0

D41.4

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Bladder

5.7

11.0

L02AE03

ATC

goserelin; implant

4.5

10.9

LCA06

NOMESCO Finland

Biopsy of endometrium

1.5

10.9

328

2235

GD5BD

NOMESCO Finland

Thorax and upper abdomen combined extensive CT examination of

3.5

10.8

108

ELB40

NOMESCO Finland

Partial parotidectomy

3.6

10.7

2411A

ICD-9 Finland

Non-toxic nodular goitre, Non-toxic multinodular goitre

5.6

10.7

Q18.0

ICD-10 Finland

Sinus, fistula and cyst of branchial cleft

5.6

10.7

2397A

ICD-9 Finland

Neoplasm of unspecified nature, Endocrine glands and other parts of nervous system

21.5

10.7

N02AA01

ATC

morphine; systemic, rectal

4.1

10.6

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.7

10.5

211

1307

BAA50

NOMESCO Finland

Lobectomy and resection of contralateral lobe of thyroid gland

14.2

10.5

R19.0

ICD-10 Finland

Intra-abdominal and pelvic swelling, mass and lump

2.6

10.4

236

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.4

10.4

697

5487

C50.20

ICD-10 Finland

Malignant tumor of the upper inner quadrant of the mammary gland,no histological veryfication

+∞

10.4

329

Kela drug reimbursment

Lenalidomide

+∞

10.4

L04AX04

ATC

lenalidomide; oral

+∞

10.4

197

Kela drug reimbursment

Sunitinib

+∞

10.4

WD515

NOMESCO Finland

Demanding therapy of malignancy with enzyme inhibitors and similar treatments

+∞

10.4

WF001

NOMESCO Finland

Preoperative radiotherapy

+∞

10.4

L01EX02

ATC

sorafenib; oral

+∞

10.4

8335/3-C73.9

ICD-O-3

Follicular carcinoma, minimally invasive of thyroid gland

+∞

10.4

L02BA03

ATC

fulvestrant; parenteral

+∞

10.4

L01CB01

ATC

etoposide; systemic

+∞

10.4

C43.50

ICD-10 Finland

Malignant melanoma of the torso without histology

+∞

10.4

1CD02, ,

NOMESCO Finland

+∞

10.4

C17.9

ICD-10 Finland

Malignant neoplasm: Small intestine, unspecified

+∞

10.4

WB133

NOMESCO Finland

Very demanding adjuvant cytostatic therapy

+∞

10.4

C34.10

ICD-10 Finland

Malignant tumor of the upper lobe, bronchus or lung without histology

+∞

10.4

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.7

10.4

190

1147

LAF11

NOMESCO Finland

Laparoscopic bilateral salpingo-oophorectomy

2.0

10.4

117

609

QDE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in lower limb

2.5

10.3

255

S77

ICPC

Malignant neoplasm of skin

18.8

10.3

E34.9

ICD-10 Finland

Endocrine disorder, unspecified

7.5

10.2

HAE99

NOMESCO Finland

Other reconstruction of breast

13.1

10.1

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.3

10.1

729

5800

TKE00

NOMESCO Finland

Needle biopsy of prostate

3.4

10.1

108

T81

ICPC

Goitre

5.3

10.1

BBA20

NOMESCO Finland

Exploration of parathyroid gland

7.9

10.1

N63

ICD-10 Finland

Unspecified lump in breast

1.8

10.1

146

825

J37.0

ICD-10 Finland

Chronic laryngitis

2.1

10.0

444

E07.9

ICD-10 Finland

Disorder of thyroid, unspecified

5.0

10.0

321

Kela drug reimbursment

Paricalcitol and cinacalcet

4.8

10.0

XGX32

NOMESCO Finland

Bronchoscopic ultrasonography

10.1

10.0

E04

ICD-10 Finland

Other nontoxic goitre

8.1

9.8

GA1AE

NOMESCO Finland

Ultrasound examination of thorax

3.1

9.8

126

AAG50

NOMESCO Finland

Stereotactic intracranial radiotherapy

13.4

9.7

E89.0

ICD-10 Finland

Postprocedural hypothyroidism

13.4

9.7

YX8VG

NOMESCO Finland

Stereotactic MRI exmaination with high intensity magnet for dose design of radiotherapy

55.2

9.6

R07.0

ICD-10 Finland

Pain in throat

1.7

9.5

176

1066

BC1CD

NOMESCO Finland

Very extensive CT of adrenal glands

7.1

9.5

9732/3-C42.1

ICD-O-3

Plasma cell myeloma of bone marrow

100.4

9.4

JN7AQ

NOMESCO Finland

Somatostatin receptor SPET med low dose CT

100.4

9.4

D44.8

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Pluriglandular involvement

30.1

9.4

GB1AA

NOMESCO Finland

Tracheal X-ray examination

17.6

9.4

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

2.9

9.4

145

L02BB04

ATC

enzalutamide; oral

+∞

9.4

8140/3-C18.2

ICD-O-3

Adenocarcinoma, NOS, of ascending colon

+∞

9.4

YN7BD

NOMESCO Finland

Extensive CT examination of spine for dose design of radiotherapy

+∞

9.4

394

Kela drug reimbursment

Palbociclib

+∞

9.4

8520/3-C50.4

ICD-O-3

Lobular carcinoma, NOS, of upper-outer quadrant of breast

+∞

9.4

C18.70

ICD-10 Finland

Malignant tumor of the sigmoid without histology

+∞

9.4

C34.82

ICD-10 Finland

Malignant overall tumor of bronchial and pulmonary adenocarcinoma

+∞

9.4

163

Kela drug reimbursment

Abiraterone and enzalutamide

+∞

9.4

8130/2-C67.9

ICD-O-3

Papillary urothelial carcinoma, non-invasive of bladder, NOS

+∞

9.4

WB402

NOMESCO Finland

Demanding antibody therapy of primary tumour

+∞

9.4

C81.1

ICD-10 Finland

Nodular sclerosis classical Hodgkin lymphoma

+∞

9.4

XX7JT

NOMESCO Finland

Somatostatin isotope ablative therapy

+∞

9.4

YN7AD

NOMESCO Finland

CT examination of spine for dose design of radiotherapy

+∞

9.4

WB121

NOMESCO Finland

Demanding neoadjuvant cytostatic therapy

+∞

9.4

C75.9

ICD-10 Finland

Malignant neoplasm: Endocrine gland, unspecified

+∞

9.4

D09.3

ICD-10 Finland

Carcinoma in situ: Thyroid and other endocrine glands

+∞

9.4

C75

ICD-10 Finland

Malignant neoplasm of other endocrine glands and related structures

+∞

9.4

C43.52

ICD-10 Finland

Malignant melanoma on the torso: 'superficial spreading' type

+∞

9.4

D48.6

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Breast

2.9

9.3

151

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.7

9.3

160

952

JN3CG

NOMESCO Finland

Extensive MRI examination of abdomen with high intensity magnet

7.3

9.2

D30.0

ICD-10 Finland

Benign neoplasm: Kidney

3.6

9.1

R74.8

ICD-10 Finland

Abnormal levels of other serum enzymes

2.4

9.1

259

H05BX01

ATC

cinacalcet; oral

4.6

9.1

BC1AD

NOMESCO Finland

CT of adrenal glands

3.4

9.0

GDB11

NOMESCO Finland

Thoracoscopic wedge resection of lung

7.0

9.0

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.3

9.0

726

5858

DQE20

NOMESCO Finland

Implantation of foreign material in vocal chord

24.1

8.9

UGB02

NOMESCO Finland

Tracheoscopy

12.6

8.9

N02AX02

ATC

tramadol; systemic, rectal

1.3

8.8

1020

8627

WX734

NOMESCO Finland

JET-ventilation

14.1

8.7

C50.9

ICD-10 Finland

Malignant neoplasm: Breast, unspecified

50.1

8.7

2533

FHL

Unilateral removal of additional egg

50.1

8.7

C08CA01

ATC

amlodipine; oral

1.3

8.7

911

7608

WX892

NOMESCO Finland

Monitored bed care

1.7

8.7

160

970

E26.0

ICD-10 Finland

Primary hyperaldosteronism

4.3

8.7

R4190

NOMESCO Finland

Nutritional therapy

2.1

8.5

364

ZYC05

NOMESCO Finland

Non-real-time text-based remote communication

2.9

8.5

137

C44.61

ICD-10 Finland

Basocellular carcinoma of the skin of the upper extremity including the shoulder

20.1

8.5

UDQ22

NOMESCO Finland

Microlaryngoscopy

4.2

8.5

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

1.7

8.4

158

961

9823/3-C42.1

ICD-O-3

B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma of bone marrow

90.3

8.4

WX1CG

NOMESCO Finland

Extensive total body MRI with high intensity magnet

90.3

8.4

D35.59

ICD-10 Finland

Other paragangliom

90.3

8.4

FM1FN

NOMESCO Finland

Heart function isotope examination

90.3

8.4

E89.1

ICD-10 Finland

Postprocedural hypoinsulinaemia

90.3

8.4

JN3DG

NOMESCO Finland

Very extensive MRI examination with high intensity magnet

7.9

8.4

C18.20

ICD-10 Finland

Malignant tumor of the ascending colon without histology

+∞

8.3

AAG00

NOMESCO Finland

Stereotactic intracranial biopsy

+∞

8.3

C79.0

ICD-10 Finland

Secondary malignant neoplasm of kidney and renal pelvis

+∞

8.3

C18.21

ICD-10 Finland

Malignant tumor of the ascending colon invasive carcinoma

+∞

8.3

C76.0

ICD-10 Finland

Malignant neoplasm of other and ill-defined sites: Head, face and neck

+∞

8.3

1501

Kela drug reimbursment

Palbociclib

+∞

8.3

C20

ICD-10 Finland

Malignant neoplasm of rectum

+∞

8.3

C19

ICD-10 Finland

Malignant neoplasm of rectosigmoid junction

+∞

8.3

YX9AW, ,

NOMESCO Finland

+∞

8.3

189

Kela drug reimbursment

Imatinib

+∞

8.3

C25.0

ICD-10 Finland

Malignant neoplasm: Head of pancreas

+∞

8.3

L01XE01

ATC

[U] imatinib

+∞

8.3

9680/3-C73.9

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of thyroid gland

+∞

8.3

C92.1

ICD-10 Finland

Chronic myeloid leukaemia [CML], BCR/ABL-positive

+∞

8.3

J01MA02

ATC

ciprofloxacin; systemic

1.3

8.3

894

7478

T81.8

ICD-10 Finland

Other complications of procedures, not elsewhere classified

2.6

8.3

173

Z80.3

ICD-10 Finland

Family history of malignant neoplasm of breast

3.1

8.2

107

ZXX02

NOMESCO Finland

Extent of procedure, 2 units

2.9

8.2

134

JN1CD

NOMESCO Finland

Very extensive CT examination of upper part of abdomen

4.2

8.2

ZXD30

NOMESCO Finland

Difficulties in perfomrming procedure

1.9

8.1

488

JFB31

NOMESCO Finland

Laparoscopic right hemicolectomy

8.1

WPA10

NOMESCO Finland

Proactive palliative care treatment plan

17.2

8.1

QA4S1

NOMESCO Finland

Photography of skin or subcutaneous tissue in face

10.0

8.0

XQ846

NOMESCO Finland

Digital dermatoscopy and registration of nevi

22.1

8.0

R49.09

ICD-10 Finland

Unspecified dysphonia

2.9

8.0

120

QBE99

NOMESCO Finland

Other excision or repair of lesion of skin of trunk

2.8

8.0

142

QX3AT

NOMESCO Finland

Ultrasound guided biopsy of subcutaneous tissue

7.2

8.0

D43.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Brain, supratentorial

7.2

8.0

D48.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Bone and articular cartilage

3.2

7.9

XJD02

NOMESCO Finland

Peroral endoscopic ultrasonography

4.0

7.9

D48.7

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Other specified sites

4.0

7.9

HA1HA

NOMESCO Finland

Tomosynthesis mammography

13.1

7.9

XJH00

NOMESCO Finland

Transanal ultrasonography

2.0

7.9

403

C07AA05

ATC

propranolol; systemic

1.3

7.8

525

4116

N05CF01

ATC

zopiclone; oral

1.3

7.8

757

6243

C43.59

ICD-10 Finland

Malignant melanoma of the trunk other or unspecified histology

45.1

7.7

3025

Kela drug reimbursment

Calcium carbonate

6.4

7.7

205

Kela drug reimbursment

Chronic hypertension

1.3

7.6

575

4582

P01AB01

ATC

metronidazole; oral, rectal

1.3

7.6

1039

8922

Z08.9

ICD-10 Finland

Follow-up examination after unspecified treatment for malignant neoplasm

18.4

7.6

PJD42

NOMESCO Finland

Excision of axillary lymph nodes

11.9

7.6

2509

FHL

Other measure in this category

25.1

7.6

YX8BD

NOMESCO Finland

Stereotactic extensive CT examination for dose design of radiotherapy

25.1

7.6

I10

ICD-10 Finland

Essential (primary) hypertension

1.2

7.6

1482

13247

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.2

7.4

1310

11565

M01AE03

ATC

ketoprofen; systemic, rectal

1.3

7.4

913

7740

Z08.8

ICD-10 Finland

Follow-up examination after other treatment for malignant neoplasm

80.3

7.4

E20

ICD-10 Finland

Hypoparathyroidism

80.3

7.4

23914

ICD-8 Finland

Neoplasm of unspecified nature of other and unspecified organs, Glandulae thyreoideae

80.3

7.4

QBB10

NOMESCO Finland

Major dressing of wound of skin of trunk

2.1

7.4

304

C50.80

ICD-10 Finland

Overall malignant tumor of the mammary gland, no histological veryfication

+∞

7.3

322

Kela drug reimbursment

Sunitinib

+∞

7.3

XX7HT

NOMESCO Finland

Chromaffine tissue (MIBG) isotope therapy

+∞

7.3

C64.80

ICD-10 Finland

Wilms tumour

+∞

7.3

C34.1

ICD-10 Finland

Malignant neoplasm: Upper lobe, bronchus or lung

+∞

7.3

C79.39

ICD-10 Finland

Secondary malignant tumor of the meninges, ventricle or other part of the brain

+∞

7.3

YJ1BD

NOMESCO Finland

Extensive CT examination of abdomen for dose design of radiotherapy

+∞

7.3

C43.70

ICD-10 Finland

Malignant melanoma of the lower extremity including the hip without histology

+∞

7.3

C78.1

ICD-10 Finland

Secondary malignant neoplasm of mediastinum

+∞

7.3

1930D

ICD-9 Finland

Malignant neoplasm of thyroid gland[CARCINOMA MEDULLARE THYREOIDEAE]

+∞

7.3

C50.2

ICD-10 Finland

Malignant neoplasm: Upper-inner quadrant of breast

+∞

7.3

192

Kela drug reimbursment

Fulvestrant

+∞

7.3

3012

Kela drug reimbursment

Cabozantinib

+∞

7.3

C77.2

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Intra-abdominal lymph nodes

+∞

7.3

C07.70

ICD-10 Finland

Malignant tumor of the superficial part of the parotid gland

+∞

7.3

C78.2

ICD-10 Finland

Secondary malignant neoplasm of pleura

+∞

7.3

CKE60

NOMESCO Finland

Brachytherapy of choroid and retina

+∞

7.3

CKE65

NOMESCO Finland

Removal of brachytherapeutic plate from eye

+∞

7.3

C83.3

ICD-10 Finland

Diffuse large B-cell lymphoma

+∞

7.3

BC5AN

NOMESCO Finland

Chromaffine and adrenergic tissue isotope imaging (MIBG)

+∞

7.3

C69.30

ICD-10 Finland

Malignant tumor of the chorioidea without histology

+∞

7.3

2374A

ICD-9 Finland

Neoplasm of uncertain behaviour of endocrine glands and nervous system, Other and unspecified endocrine glands

+∞

7.3

C83.00

ICD-10 Finland

Lymphocytic lymphoma

+∞

7.3

NK6AQ

NOMESCO Finland

Whole body bone SPET with low dose CT

+∞

7.3

8010/3-C74.9

ICD-O-3

Carcinoma, NOS, of adrenal gland, NOS

+∞

7.3

L01EA01

ATC

imatinib; oral

+∞

7.3

8344/3-C73.9

ICD-O-3

Papillary carcinoma, columnar cell of thyroid gland

+∞

7.3

8090/3-C44.4

ICD-O-3

Basal cell carcinoma, NOS, of skin of scalp and neck

+∞

7.3

C34.11

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary epidermoid carcinoma

+∞

7.3

C43.62

ICD-10 Finland

Malignant melanoma of upper extremity including shoulder: 'superficial spreading' type

+∞

7.3

C77.8

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Lymph nodes of multiple regions

+∞

7.3

C50.59

ICD-10 Finland

Malignant tumor of the lower outer quadrant of the mammary gland, other or undeterminated histology

+∞

7.3

TKE10

NOMESCO Finland

Puncture of prostate

+∞

7.3

L01EF01

ATC

palbociclib; oral

+∞

7.3

C80.90

ICD-10 Finland

Malignant tumor without specified localization without histology

+∞

7.3

C79.7

ICD-10 Finland

Secondary malignant neoplasm of adrenal gland

+∞

7.3

C67.2

ICD-10 Finland

Malignant neoplasm: Lateral wall of bladder

+∞

7.3

TPX15

NOMESCO Finland

Removal of vascular injection port

10.9

7.3

E27.3

ICD-10 Finland

Drug-induced adrenocortical insufficiency

4.2

7.3

M01AE01

ATC

ibuprofen; systemic, rectal

1.3

7.2

2491

23718

A01AB09

ATC

miconazole; local oral

1.5

7.2

202

1355

R21

ICPC

Throat symptom/complaint

1.3

7.2

500

3936

HAC15

NOMESCO Finland

Subcutaneous mastectomy with excision of mamilla

30.1

7.1

KCD05

NOMESCO Finland

Excision of bladder lesion during urinary tract endoscopy with photodynamic diagnosis (PDD)

20.1

7.1

GEB30

NOMESCO Finland

Mediastinotomy and excision of lesion

20.1

7.1

E24.9

ICD-10 Finland

Cushing syndrome, unspecified

20.1

7.1

EWE00

NOMESCO Finland

Reoperation for deep haemorrhage in surgery of teeth, jaws, mouth and pharynx

20.1

7.1

-1, ,

ICD-10 Finland

1.8

7.1

105

599

WVA30

NOMESCO Finland

Intramuscular and subcutaneous injection

7.9

7.1

RP210, ,

NOMESCO Finland

12.0

7.1

WZC15, ,

NOMESCO Finland

12.0

7.1

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

1.9

7.0

455

A02BC05

ATC

esomeprazole; systemic

1.2

7.0

1038

8972

HAB00

NOMESCO Finland

Excision of lesion of mammary gland

2.2

7.0

257

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

1.7

7.0

115

676

R59.9

ICD-10 Finland

Enlarged lymph nodes, unspecified

3.4

7.0

XF600

NOMESCO Finland

Bloodpressure measurement

1.7

6.9

130

794

D37.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Stomach

7.5

6.9

KAC00

NOMESCO Finland

Nephrectomy

13.8

6.9

L91.0

ICD-10 Finland

Hypertrophic scar

2.8

6.8

114

LC2DE

NOMESCO Finland

Demanding ultrsound examination of uterus, parametrium and lower part of abdomen with speciel methods

1.8

6.8

104

599

Q18.8

ICD-10 Finland

Other specified congenital malformations of face and neck

8.3

6.8

D23.3

ICD-10 Finland

Benign neoplasm: Skin of other and unspecified parts of face

2.2

6.8

261

WF099

NOMESCO Finland

Other radiotherapy

9.3

6.8

PJ4AT

NOMESCO Finland

Labeling lymphnode with ultrasound guidance

40.1

6.8

C44.21

ICD-10 Finland

Basocellular carcinoma of the skin of the outer ear and the outer ear canal

40.1

6.8

Y83.8

ICD-10 Finland

Other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.1

6.7

289

D38.3

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Mediastinum

7.2

6.7

OAB74

NOMESCO Finland

Nutritional guidance related to treatment and rehabilitation for medical condition

3.3

6.7

OAA41

NOMESCO Finland

Health check based on individual needs

22.6

6.7

C44.71

ICD-10 Finland

Basocellular carcinoma of the skin of the lower extremity including the hip

22.6

6.7

JN5KR

NOMESCO Finland

Very extensive PET-CT of upper body metabolism (eyebrows to thighs)

22.6

6.7

UKC02

NOMESCO Finland

Cystoscopy

1.4

6.6

276

2002

KA3AT

NOMESCO Finland

Biopsy of kidney with ultrasound guidance

2.9

6.6

105

HA3AT

NOMESCO Finland

Pucture of mammary gland cyst with ultrasound examination

7.8

6.6

D37.2

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Small intestine

7.8

6.6

E05.4

ICD-10 Finland

Thyrotoxicosis factitia

12.3

6.6

JN5ER

NOMESCO Finland

PET-CT of receptors in whole body

12.3

6.6

ZX121

NOMESCO Finland

Central venous catheter

12.3

6.6

XX1AT

NOMESCO Finland

Other puncture with ultrasound guidance

3.4

6.5

E21.2

ICD-10 Finland

Other hyperparathyroidism

4.2

6.5

KAD01

NOMESCO Finland

Percutaneous endoscopic partial nephrectomy

10.0

6.5

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

2.0

6.5

320

KF8AE

NOMESCO Finland

Ultrasound examination of scrotum

2.6

6.5

135

JN4SR

NOMESCO Finland

Very extensive PET-CT of receptors in whole body

70.0

6.4

C16.9

ICD-10 Finland

Malignant neoplasm: Stomach, unspecified

70.0

6.4

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

1.7

6.4

121

740

KED22

NOMESCO Finland

Transurethral resection of prostate

1.9

6.4

370

DWD00

NOMESCO Finland

Reoperation for superficial heamorrhage in surgery of ear, nose and larynx

14.3

6.4

JC2KB

NOMESCO Finland

Functional X-ray examination of swallowing

2.7

6.3

119

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

1.7

6.3

105

620

E03.2

ICD-10 Finland

Hypothyroidism due to medicaments and other exogenous substances

5.2

6.3

D22.7

ICD-10 Finland

Melanocytic naevi of lower limb, including hip

2.4

6.3

179

2502

FHL

Thyroid exploration and possible biopsy

18.0

6.3

WD315

NOMESCO Finland

Multiple therapy of methastized malignancy with biomodifiers

18.0

6.3

H01CB02

ATC

octreotide; parenteral

18.0

6.3

GDC00

NOMESCO Finland

Lobectomy of lung

18.0

6.3

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

1.5

6.3

180

1216

C34.90

ICD-10 Finland

Malignant tumor in unspecified location in bronchus and lung without histology

+∞

6.3

ZZQ10

NOMESCO Finland

Free microvascular graft of skin and muscle

+∞

6.3

C73, C75,

ICD-10 Finland

+∞

6.3

C78.8

ICD-10 Finland

Secondary malignant neoplasm of other and unspecified digestive organs

+∞

6.3

L01EX07

ATC

cabozantinib; oral

+∞

6.3

C25.9

ICD-10 Finland

Malignant neoplasm: Pancreas, unspecified

+∞

6.3

L01EX01

ATC

sunitinib; oral

+∞

6.3

C50.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of breast

+∞

6.3

1523, ,

Kela drug reimbursment

+∞

6.3

8370/3-C74.9

ICD-O-3

Adrenal cortical carcinoma of adrenal gland, NOS

+∞

6.3

JJB10

NOMESCO Finland

Atypcal resection of liver

+∞

6.3

5639

FHL

Other measure in this category

+∞

6.3

C50.10

ICD-10 Finland

Malignant tumor of the central part of the mammary gland, no histological veryfication

+∞

6.3

DQB60

NOMESCO Finland

Aryotenoidectomy

+∞

6.3

8021/3-C73.9

ICD-O-3

Carcinoma, anaplastic, NOS, of thyroid gland

+∞

6.3

JN5AP

NOMESCO Finland

Total body PET (1 picture)

+∞

6.3

8140/3-C18.0

ICD-O-3

Adenocarcinoma, NOS, of cecum

+∞

6.3

8140/3-C34.3

ICD-O-3

Adenocarcinoma, NOS, of lower lobe, lung

+∞

6.3

8140/3-C34.9

ICD-O-3

Adenocarcinoma, NOS, of lung, NOS

+∞

6.3

4707

FHL

Dissection Colli radicalis

+∞

6.3

C83.39

ICD-10 Finland

Diffuse non-Hodgkin's large cell lymphoma UNS

+∞

6.3

C24.9

ICD-10 Finland

Malignant neoplasm: Biliary tract, unspecified

+∞

6.3

C85.1

ICD-10 Finland

B-cell lymphoma, unspecified

+∞

6.3

C50.19

ICD-10 Finland

Malignant tumor of the central part of the mammary gland, other or undeterminated histology

+∞

6.3

WB111

NOMESCO Finland

Multiple neoadjuvant cytostatic therapy

+∞

6.3

8140/3-C34.1

ICD-O-3

Adenocarcinoma, NOS, of upper lobe, lung

+∞

6.3

8720/3-C44.7

ICD-O-3

Malignant melanoma, NOS, of skin of lower limb and hip

+∞

6.3

3054, ,

Kela drug reimbursment

+∞

6.3

8317/3-C64.9

ICD-O-3

Renal cell carcinoma, chromophobe type of kidney, NOS

+∞

6.3

1930A, ,

ICD-10 Finland

+∞

6.3

352

Kela drug reimbursment

Abiraterone and enzalutamide

+∞

6.3

HAC25

NOMESCO Finland

Radical mastectomy

+∞

6.3

C50.1

ICD-10 Finland

Malignant neoplasm: Central portion of breast

+∞

6.3

C77.3

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Axillary and upper limb lymph nodes

+∞

6.3

C43.53

ICD-10 Finland

Malignant melanoma of the torso nodular

+∞

6.3

C34.19

ICD-10 Finland

Malignant tumor of the upper lobe, bronchus or lung other or unspecified histology

+∞

6.3

JJB71

NOMESCO Finland

Laparoscopic resection of liver

+∞

6.3

WW402

NOMESCO Finland

Leucoferesis

+∞

6.3

BWA00

NOMESCO Finland

Repair of wound dehiscence in endocrine surgery

+∞

6.3

NK6BQ

NOMESCO Finland

Whole body extensive bone SPET with low dose CT

26.7

6.2

GBB13

NOMESCO Finland

Revision of tracheostomy

26.7

6.2

KKB10

NOMESCO Finland

Excision of retroperitoneal tumour

26.7

6.2

E27.4

ICD-10 Finland

Other and unspecified adrenocortical insufficiency

6.3

6.2

BA3AT, ,

SPAT

12.5

6.1

JN3KE

NOMESCO Finland

Abdominal ultrasound with added contrast

8.6

6.0

Y69

ICD-10 Finland

Unspecified misadventure during surgical and medical care

2.8

6.0

105

A06AC01

ATC

ispaghula (psylla seeds); oral

1.3

6.0

629

5211

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

1694

1559

24.57

307.65

7.3

3.0

4.50

4.51

pmol/l

0.12

1645

1370

(4035726) Immunohistochemistry procedure

695

665

13.41

307.65

1.5

1.3

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

665

320

26.63

307.65

1.5

1.2

—

(3018418) pH of Serum or Plasma

1717

6303

5.20

307.65

8.5

3.2

7.40

1.30

395

1046

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

1933

112

510.70

307.65

7.9

1.1

56.41

139.73

u/ml

0.70

725

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

2144

9738

5.55

307.65

10.7

5.2

1.20

1.22

mmol/l

28.55

2064

8687

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

1956

2831.13

307.65

7.7

1.2

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

797

1746

5.91

307.65

3.5

3.7

52.05

84.69

ng/l

29.34

713

1503

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

2318

10829

6.58

307.65

12.8

5.6

1.20

1.22

mmol/l

39.69

1954

9208

(3015377) Calcium [Moles/volume] in Serum or Plasma

1544

7085

3.51

241.68

4.3

2.0

2.30

2.36

mmol/l

36.85

1422

6015

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

2738

19670

7.49

192.72

11.3

4.1

17.65

14.70

pmol/l

307.65

2658

18038

(3002256) Pathology report gross observation

639

1968

3.88

178.41

1.4

1.1

—

(40768804) Tissue Pathology biopsy report

1522

8336

2.73

152.03

2.4

1.7

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

1692

9858

2.71

147.86

2.7

2.3

—

(3044640) Blood type and Crossmatch panel - Blood

1256

6351

2.72

145.55

2.5

2.0

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

768

3008

3.11

143.46

4.1

2.8

0.82

0.83

mmol/l

1.72

738

2773

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

1686

10199

2.55

130.11

2.9

2.3

79.05

78.07

nmol/l

0.79

1596

9114

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

378

1011

4.15

126.28

4.1

1.4

20.06

2.61

ug/l

0.88

293

739

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

226

435

5.55

112.50

2.6

2.8

—

(3024561) Albumin [Mass/volume] in Serum or Plasma

1499

8989

2.37

112.07

5.6

3.9

36.23

36.22

g/l

0.04

1423

8234

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

485

1660

3.31

111.48

7.6

2.9

1.21

1.23

mmol/l

11.44

456

1375

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

185

322

6.07

102.31

3.1

1.2

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

2773

23053

5.19

95.86

14.7

4.9

1.75

2.08

mu/l

0.97

2665

21294

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

2320

17487

2.60

94.89

9.8

5.4

76.57

75.22

u/l

1.06

2245

16216

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

187

354

5.58

94.57

3.2

1.2

0.48

0.39

nmol/l

0.16

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

798

3883

2.45

92.35

3.8

2.1

2.40

2.44

mmol/l

10.97

725

3311

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

1631

10700

2.19

91.30

7.6

3.8

11.01

11.20

umol/l

0.20

1563

9974

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

925

4849

2.33

90.03

2.4

2.0

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

164

314

5.47

81.80

3.1

1.2

—

nmol/l

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

580

2622

2.51

77.20

6.0

5.4

1.08

1.05

mmol/l

2.31

542

2415

(3013650) Neutrophils [#/volume] in Blood by Automated count

1782

12604

2.07

75.71

10.5

6.7

3.90

4.11

e9/l

3.65

1574

10897

(3010838) Calcium [Moles/time] in 24 hour Urine

188

445

4.45

72.87

2.4

2.1

5.73

5.28

mmol/24h

0.75

177

380

(40768795) Lymph node Pathology biopsy report

15.95

71.01

1.2

1.1

—

(3035637) Corticotropin [Mass/volume] in Plasma

119

220

5.60

61.55

2.9

1.5

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

1784

13163

1.92

60.72

5.8

4.2

6.51

6.63

mmol/l

1.84

1697

12166

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

196

566

3.64

57.58

2.2

1.6

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

20.78

54.02

1.2

—

(3011985) Renin [Units/volume] in Plasma

132

310

4.41

51.55

2.6

1.4

45.80

48.17

mu/l

0.07

122

275

(3033658) Prothrombin time (PT) actual/Normal

867

5303

1.90

50.53

4.2

3.4

94.48

92.43

1.86

853

5141

(3036481) Cortisol [Moles/volume] in Serum or Plasma

448

2151

2.28

50.36

3.4

1.8

384.08

363.22

nmol/l

0.49

424

1952

(3022217) INR in Platelet poor plasma by Coagulation assay

1356

9657

1.76

46.89

12.1

14.3

1.16

1.24

inr

3.90

456

2881

(40768793) Breast Pathology biopsy report

179

5.04

40.90

1.4

1.2

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

412

2079

2.14

40.39

3.5

2.9

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

113

296

3.93

38.13

1.5

1.4

277.83

346.90

pmol/l

1.60

103

259

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

368

1825

2.16

37.57

5.5

3.0

234.18

232.09

u/l

0.14

349

1708

(3003396) Base excess in Arterial blood by calculation

404

2098

2.07

36.51

7.4

7.7

1.16

1.32

mmol/l

0.38

330

1640

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

406

2118

2.07

36.22

7.4

7.6

5.14

5.09

kpa

0.60

385

2014

(3027801) Oxygen [Partial pressure] in Arterial blood

406

2118

2.07

36.22

7.4

7.6

12.77

11.87

kpa

2.68

385

2012

(3003694) ABO and Rh group [Type] in Blood

887

5926

1.71

36.15

1.4

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

230

954

2.53

35.42

8.9

11.4

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

131

401

3.37

35.08

2.8

2.0

302.09

27.44

u/ml

0.80

108

315

(3012565) Volume of 24 hour Urine

6.34

34.69

2.7

2.1

1925.00

1941.40

0.04

(3016502) Oxygen saturation in Arterial blood

366

1868

2.10

34.54

7.7

8.2

96.03

95.31

1.28

352

1793

(3023368) Bacteria identified in Blood by Culture

760

4996

1.71

32.23

4.8

3.8

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

335

1707

2.09

31.63

8.1

8.5

123.58

122.51

g/l

0.40

325

1657

(3019550) Sodium [Moles/volume] in Serum or Plasma

2723

24939

2.40

31.10

19.9

13.1

139.80

139.78

mmol/l

0.17

2682

24272

(40760892) CBC W Ordered Manual Differential panel - Blood

1387

10716

1.56

29.74

7.5

6.0

—

(3044889) 12 lead EKG panel

1989

16698

1.60

29.45

4.2

3.5

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

313

1597

2.08

29.37

2.0

2.2

0.23

0.21

g/l

4.20

300

1455

(3023103) Potassium [Moles/volume] in Serum or Plasma

2723

25027

2.34

29.30

20.3

13.2

3.93

3.96

mmol/l

1.19

2672

24310

(3002030) Lymphocytes/100 leukocytes in Blood

1418

11047

1.55

29.04

7.1

5.9

27.78

28.87

3.15

1348

10332

(3006504) Eosinophils/100 leukocytes in Blood

1376

10663

1.55

28.76

7.1

5.8

2.76

2.93

1.95

1306

9920

(3019069) Monocytes/100 leukocytes in Blood

1382

10732

1.55

28.53

7.3

6.1

8.46

8.38

0.44

1311

10003

(3022096) Basophils/100 leukocytes in Blood

1333

10308

1.54

27.80

7.1

5.9

0.67

0.70

1.29

1262

9555

(3019198) Lymphocytes [#/volume] in Blood

1495

11860

1.54

27.66

6.7

5.7

1.92

e9/l

0.00

1335

10505

(40758558) Short blood count panel - Blood

783

5362

1.63

27.66

7.7

4.8

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

166

667

2.58

27.24

1.8

1.9

4.57

4.59

iu/l

0.01

247

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

2648

24189

2.04

27.11

18.2

11.3

20.03

20.96

mg/l

0.87

2211

18463

(3001604) Monocytes [#/volume] in Blood

1449

11501

1.52

26.18

6.7

5.6

0.57

e9/l

0.02

1264

9961

(3006315) Basophils [#/volume] in Blood

1448

11537

1.51

25.38

6.7

5.6

0.04

e9/l

1.36

1261

9984

(3013115) Eosinophils [#/volume] in Blood

1493

11973

1.51

25.35

7.0

5.8

0.19

e9/l

0.46

1325

10541

(3002385) Erythrocyte distribution width [Ratio]

2365

21048

1.66

24.31

22.9

13.3

14.50

14.87

2.76

2344

20643

(3047181) Lactate [Moles/volume] in Blood

154

631

2.52

24.26

5.0

7.3

1.28

1.25

mmol/l

0.11

135

547

(3018010) Neutrophils/100 leukocytes in Blood

1379

10951

1.49

24.09

6.9

5.7

57.58

56.71

2.01

1307

10226

(3039000) Anion gap in Blood

113

419

2.77

21.75

5.5

9.1

11.21

11.24

mmol/l

0.02

104

369

(3018572) Chloride [Moles/volume] in Blood

113

420

2.76

21.65

5.5

9.1

105.79

104.91

mmol/l

1.65

104

370

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

117

4.51

21.50

1.4

4.13

4.42

umol/l

0.17

109

(3021589) Normoblasts [#/volume] in Blood

1286

10263

1.45

20.82

13.2

7.9

0.00

e9/l

0.90

1082

8392

(3019225) pH of Specimen

365

2186

1.77

20.75

9.1

3.5

—

(3013707) Erythrocyte sedimentation rate by Westergren method

2069

18157

1.48

19.66

4.5

4.1

12.12

11.28

mm/h

1.79

1928

16835

(3042936) Bacteria identified in Isolate by Culture

436

2784

1.67

19.56

2.0

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

212

3.36

19.15

1.5

1.3

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

2490

22820

1.63

18.61

17.8

10.1

83.53

81.85

ml/min/173m2

3.64

2197

18340

(3000991) Gas panel - Venous blood

277

1577

1.84

18.59

9.9

8.2

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

129

553

2.39

18.46

2.3

3.1

—

(36304419) Bacteria [Presence] in Urine

778

5760

1.48

17.98

3.0

2.8

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

222

1191

1.94

17.89

6.2

7.4

25.01

24.65

mmol/l

0.86

209

1126

(40761511) CBC panel - Blood by Automated count

2707

25446

1.90

17.65

18.2

10.9

—

(3018095) Leukocytes [#/volume] in Urine

993

7728

1.43

17.55

3.6

3.4

68.08

104.84

e6/l

1.02

726

5239

(3002582) Erythrocytes [#/volume] in Urine

845

6382

1.46

17.55

3.2

3.0

47.44

68.18

e6/l

0.64

659

4795

(3026782) Osmolality of Urine

595

4190

1.53

17.46

2.7

522.42

527.86

mosm/kgh2o

0.25

517

3544

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

202

1060

1.97

17.36

2.0

1.5

39.88

23.31

u/ml

1.05

196

1008

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

185

944

2.02

17.21

10.3

9.7

24.64

24.46

mmol/l

0.34

178

920

(3045142) Bone marrow Pathology biopsy report

126

3.94

17.07

1.6

1.2

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

4.69

17.04

1.5

248.50

70.87

nmol/24h

1.58

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

472

3176

1.58

16.93

2.2

1.7

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

316

2.77

16.90

1.3

1.5

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

464

3112

1.58

16.88

2.9

2.1

29.64

29.71

0.10

453

2996

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

416

2719

1.62

16.86

3.0

2.6

22.27

23.30

0.68

341

2308

(3019060) Gas panel - Arterial blood

227

1253

1.88

16.77

4.5

5.4

—

(3011412) CD3 cells [#/volume] in Blood

146

3.68

16.76

2.9

2.3

1.17

1.19

e9/l

0.08

131

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

+∞

16.68

1.1

0.0

—

(3000850) Epithelial cells [#/volume] in Urine

621

4465

1.50

16.38

2.6

2.4

4.75

6.41

e6/l

3.14

555

3968

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

958

7488

1.42

16.22

3.8

2.7

28.86

33.65

u/l

1.36

908

7098

(40761536) Microorganisms panel - Urine sediment

304

1870

1.70

15.55

4.0

3.8

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

345

2205

1.64

15.23

2.0

1.7

—

(3030467) Casts [#/volume] in Urine by Automated count

774

5882

1.43

15.14

3.1

2.9

0.37

e6/l

0.02

606

4398

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

110

3.95

15.12

1.7

1.9

8.03

8.26

nmol/l

0.02

(3031040) Bacteria [#/volume] in Urine by Automated count

1770

15436

1.37

14.90

4.6

4.2

1761.84

2043.45

e6/l

0.07

196

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

158

804

2.02

14.82

4.9

5.9

1.71

1.64

0.47

149

747

(3004789) Transferrin [Mass/volume] in Serum or Plasma

438

2983

1.55

14.76

2.9

2.4

2.35

2.38

g/l

0.67

407

2764

(3007930) Methemoglobin/Hemoglobin.total in Blood

157

800

2.02

14.67

4.8

6.0

0.94

0.89

0.99

148

746

(3022948) Iron [Moles/volume] in Serum or Plasma

473

3285

1.53

14.57

2.9

2.4

12.79

13.65

umol/l

1.71

443

3050

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

110

3.86

14.31

2.6

2.2

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

340

2210

1.61

13.97

2.0

1.7

—

(3020779) Urea [Moles/volume] in Serum or Plasma

269

1652

1.69

13.81

9.7

7.5

9.15

9.50

mmol/l

0.38

251

1580

(3014111) Lactate [Moles/volume] in Serum or Plasma

271

1675

1.68

13.58

10.2

6.8

1.23

1.36

mmol/l

1.76

264

1635

(3005719) IgG [Mass/volume] in Serum or Plasma

263

1622

1.68

13.28

3.5

2.3

10.32

10.62

g/l

0.38

239

1483

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

232

1396

1.72

12.83

1.7

1.6

—

(40768800) Prostate Pathology biopsy report

4.78

12.59

1.2

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

412

2.30

12.44

3.3

3.7

58.34

56.83

0.51

412

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

173

3.04

12.30

1.2

1.1

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

190

2.93

12.19

1.2

—

(3010421) pH of Blood

104

488

2.17

12.12

4.7

3.8

7.41

7.42

0.73

443

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

353

2394

1.54

12.01

3.0

2.3

7.82

6.80

umol/l

0.33

311

2027

(3002032) Base excess in Venous blood by calculation

291

1890

1.60

11.95

6.2

3.6

2.23

1.92

mmol/l

0.75

248

1612

(3017181) Myelocytes/100 leukocytes in Blood

271

1731

1.62

11.92

4.4

4.0

1.43

0.63

3.61

100

408

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

722

5628

1.38

11.69

2.5

2.2

2.97

2.86

mg/l

0.55

625

4799

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

882

7100

1.35

11.60

2.7

2.3

57.04

58.18

u/l

0.14

818

6489

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

5.71

11.47

1.5

1.7

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

1248

10579

1.31

11.40

3.3

2.8

119.02

100.80

ug/l

2.28

1157

9823

(3012501) Base excess in Blood by calculation

404

2.24

11.27

5.1

4.0

2.48

2.57

mmol/l

0.11

262

(3000060) B lymphocytes [#/volume] in Blood

5.14

11.26

3.5

2.0

258.46

176.55

e6/l

0.36

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

177

2.91

11.23

2.0

1.5

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

4.93

11.20

3.1

2.3

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

5.56

11.17

1.3

1.5

—

(40760888) Immunoglobulin light chains.free panel - Serum

413

2.22

11.11

3.8

1.4

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

407

2.22

11.08

2.2

1.4

—

(3021440) Promyelocytes/100 leukocytes in Blood

259

1667

1.61

11.04

4.4

4.0

0.20

0.06

1.41

342

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

112

3.42

10.96

1.5

1.6

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

286

1892

1.57

10.85

6.3

3.6

5.88

5.85

kpa

0.21

276

1836

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

105

3.46

10.56

3.5

2.2

0.24

0.21

e9/l

0.37

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

110

3.39

10.54

3.4

2.2

484.93

448.33

e6/l

0.19

(3002179) Metamyelocytes/100 leukocytes in Blood

249

1607

1.60

10.49

4.0

3.8

1.34

0.50

1.70

368

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

103

511

2.05

10.44

1.9

1.7

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

343

2.28

10.23

1.2

—

(3042631) Mycobacterium sp identified in Specimen

217

2.61

10.06

3.4

—

(3023520) Reticulocytes [#/volume] in Blood

236

1526

1.59

9.87

3.2

2.3

70.97

71.30

e9/l

0.04

173

1143

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

394

2.17

9.86

2.3

1.4

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

173

1033

1.72

9.86

2.1

2.2

10.76

13.33

nmol/l

3.37

153

924

(3022145) Colonoscopy Study observation

347

2443

1.48

9.81

1.4

1.3

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

276

1858

1.54

9.67

1.2

141.16

147.63

iu/ml

0.10

108

728

(3027945) Reticulocytes/100 erythrocytes in Blood

304

2090

1.51

9.66

3.6

2.3

1.77

1.78

0.03

274

1841

(3037756) Immunofixation for Serum or Plasma

340

2.24

9.58

1.9

1.2

—

(40767503) Oxygen content in Capillary blood by calculation

379

2.17

9.58

2.5

2.4

15.72

16.52

0.86

195

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

103

528

1.99

9.56

7.4

4.0

1.51

1.47

mg/l

0.18

479

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

328

2.26

9.53

4.9

6.1

1237.10

423.87

iu/ml

—

(3026008) Bacteria identified in Urine by Culture

863

7085

1.31

9.52

3.0

—

(3028026) IgM [Mass/volume] in Serum or Plasma

202

1270

1.63

9.48

2.3

1.5

1.35

1.24

g/l

0.23

184

1164

(3025159) Blasts/100 leukocytes in Blood

244

1612

1.56

9.30

4.4

4.0

0.17

0.05

1.06

296

(3033923) Metanephrine [Moles/time] in 24 hour Urine

4.06

9.24

1.4

1.1

53.61

0.71

umol/24h

0.50

(3013512) EKG study

810

6617

1.31

9.21

3.5

3.7

—

(3028626) Oxygen [Partial pressure] in Capillary blood

453

2.04

9.18

3.7

4.4

8.53

8.36

kpa

0.41

443

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

216

2.53

9.13

3.1

2.0

448.00

23.28

u/ml

0.52

192

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

107

3.20

8.90

1.6

1.3

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

101

531

1.93

8.75

2.5

3.9

0.32

0.36

u/ml

0.86

309

(3027273) Bicarbonate [Moles/volume] in Venous blood

163

991

1.68

8.72

3.2

3.1

25.84

25.38

mmol/l

0.84

155

955

(3006245) CD3-CD19+ cells/100 cells in Blood

3.87

8.68

3.3

2.0

14.40

10.37

0.62

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

279

2.29

8.54

2.4

1.4

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

218

2.46

8.47

1.2

1.1

82.29

58.37

u/l

0.88

195

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

+∞

8.33

1.0

0.0

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

197

1272

1.59

8.31

5.6

3.0

125.23

131.14

g/l

3.02

190

1231

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

114

635

1.83

8.28

2.5

1.9

15.33

1.88

ug/l

0.52

553

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

552

4328

1.34

8.27

3.9

3.6

102.25

444.18

ng/l

6.26

409

3165

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

235

2.37

8.11

1.9

1.4

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

187

1203

1.59

8.01

1.5

1.4

30.51

28.67

iu/l

0.31

159

1051

(3041096) Erythrocytes [Presence] in Urine by Automated

764

6296

1.29

7.93

3.4

3.2

—

(3020630) Protein [Mass/volume] in Serum or Plasma

236

1604

1.51

7.92

3.2

1.5

66.49

67.24

g/l

0.79

220

1432

(3021901) Oxygen saturation in Capillary blood

330

2.12

7.79

2.8

2.9

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

128

2.84

7.69

1.5

1.6

25190.91

83816.18

e6/l

0.61

(3007853) Bacteria identified in Skin by Aerobe culture

347

2555

1.41

7.66

1.7

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

1749

15913

1.25

7.62

3.2

2.9

45.12

41.63

u/l

1.21

1628

14795

(1616796) Gas panel - Central venous blood

402

1.99

7.56

4.8

3.6

—

(3037467) Urinalysis macro (dipstick) panel - Urine

1795

16392

1.25

7.51

4.6

4.1

—

(21494814) CD8 cells/100 lymphocytes in Specimen

3.91

7.43

1.6

2.4

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

425

3258

1.36

7.33

2.8

2.6

3.69

3.43

e6/l

0.16

224

1702

(3015235) Bicarbonate [Moles/volume] in Capillary blood

485

1.88

7.30

2.8

3.6

24.94

mmol/l

0.01

474

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

+∞

7.29

1.3

0.0

—

(40768806) Pleura Pathology biopsy report

3.11

7.28

1.4

1.5

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

459

3565

1.34

7.26

2.7

2.5

0.89

1.29

e6/l

1.60

251

2007

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

571

4579

1.31

7.21

1.5

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

103

582

1.80

7.19

4.0

1.5

28.40

30.89

mg/l

0.32

471

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

122

2.81

7.16

2.1

1.4

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

103

583

1.79

7.15

4.0

1.5

42.01

39.49

mg/l

0.22

474

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

100

561

1.81

7.15

3.8

1.4

1.08

1.48

ratio

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

308

2.10

7.14

1.7

1.4

0.24

0.41

nmol/l

1.95

255

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

306

2.08

6.87

1.8

1.4

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

256

1823

1.44

6.81

3.6

3.0

173.03

177.49

ng/l

0.06

233

1657

(3000012) Reticulocyte production index

210

2.31

6.77

2.1

1.8

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

135

838

1.64

6.73

2.2

2.0

10759.61

4330.62

u/l

0.56

352

(3009542) Hematocrit [Volume Fraction] of Blood

2794

27226

1.64

6.55

29.0

16.9

40.14

40.39

0.61

2609

25417

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

988

8554

1.23

6.47

3.5

3.4

45.87

55.58

ng/l

0.27

636

5423

(3052851) Hemolysis interference index of Serum or Plasma

106

624

1.73

6.46

3.4

3.2

—

(3023199) Leukocytes [#/volume] in Pleural fluid

147

2.54

6.43

1.5

1.6

3149.62

2869.75

e6/l

0.06

112

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

377

1.93

6.41

1.4

1.7

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

537

1.78

6.36

1.7

1.4

14.28

10.65

u/l

1.28

436

(3009261) Glucose [Presence] in Urine by Test strip

1323

11836

1.22

6.21

3.8

3.6

0.00

0.01

estimate

1.32

303

1990

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

3.97

6.16

1.7

2.5

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

405

1.87

6.10

1.6

1.4

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

3.03

6.07

2.2

1.3

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

3.03

6.07

2.2

1.4

—

(3024731) MCV [Entitic volume]

2795

27273

1.61

6.06

28.4

16.8

90.08

90.83

17.45

2774

26848

(3007461) Platelets [#/volume] in Blood

2794

27261

1.60

6.06

28.6

16.8

257.59

257.07

e9/l

0.17

2749

26524

(3010813) Leukocytes [#/volume] in Blood

2795

27274

1.61

6.05

28.5

16.8

6.55

6.62

e9/l

0.84

2746

26435

(3035941) MCH [Entitic mass]

2795

27276

1.61

6.02

28.4

16.7

29.97

30.24

14.65

2774

26849

(3000963) Hemoglobin [Mass/volume] in Blood

2796

27289

1.61

6.01

28.7

16.9

134.85

135.64

g/l

2.37

2775

26860

(3026361) Erythrocytes [#/volume] in Blood

2795

27280

1.60

5.97

28.5

16.8

4.53

4.51

e12/l

1.60

2745

26448

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

2685

26000

1.42

5.94

13.0

8.7

25.02

25.31

u/l

0.47

2614

24989

(3045788) Cell count panel - Pleural fluid

118

2.64

5.89

1.6

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

152

1005

1.54

5.85

1.9

2.0

36.66

39.27

u/l

0.94

133

885

(3012441) Differential panel - Pleural fluid

120

2.60

5.71

1.5

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

233

2.12

5.71

1.8

1.3

—

(3021601) Nitrite [Presence] in Urine by Test strip

1304

11717

1.20

5.67

5.1

4.8

0.00

estimate

0.50

303

2032

(3004588) Protein electrophoresis panel - Serum or Plasma

198

1395

1.45

5.61

2.7

1.4

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

8.49

5.55

4.9

1.2

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

291

1.98

5.50

2.1

1.4

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

291

1.98

5.50

2.1

1.4

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

2.72

5.26

2.1

1.3

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

5.41

5.22

1.3

1.1

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

606

1.64

5.05

2.2

2.1

10.53

11.25

mg/l

0.40

552

(3002079) Sodium [Moles/time] in 24 hour Urine

110

2.56

5.04

1.2

1.3

147.59

157.21

mmol/24h

0.27

110

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

546

1.67

4.99

1.3

1.2

—

(3017704) Immunofixation for Urine

106

2.56

4.88

1.5

1.2

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

559

1.65

4.83

4.1

2.6

3.47

3.55

g/l

0.19

522

(3035350) Ketones [Presence] in Urine by Test strip

1292

11714

1.18

4.80

3.8

3.6

0.00

estimate

1.47

320

2177

(3007164) IgA [Mass/volume] in Serum or Plasma

575

4830

1.24

4.80

1.7

1.3

2.35

g/l

0.00

373

2864

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

617

5231

1.23

4.71

2.1

1.8

1.20

1.04

mg/l

0.42

475

3916

(3008757) Leukocyte morphology finding [Identifier] in Blood

158

2.23

4.69

6.3

3.3

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

821

7165

1.20

4.66

2.3

2.1

161.33

199.70

u/l

0.92

790

6691

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

5.02

4.62

1.2

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

219

2.02

4.61

1.9

1.3

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

186

2.11

4.57

1.2

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

135

2.31

4.52

1.7

1.5

6.58

7.79

u/l

0.19

113

(3032352) Blasts [#/volume] in Cerebral spinal fluid

10.02

4.52

1.8

1.0

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

364

1.78

4.50

1.5

109.27

107.30

u/ml

0.07

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

117

2.41

4.47

1.1

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

4.39

4.43

1.5

1.1

29.41

1.75

umol/24h

0.52

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

265

1.90

4.40

1.9

1.3

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

1014

9059

1.18

4.37

4.0

3.7

—

(40768797) Stomach Pathology biopsy report

402

3277

1.26

4.36

1.3

1.2

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

310

2446

1.30

4.36

1.7

1.5

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

131

2.30

4.36

1.6

1.4

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

451

1.68

4.35

1.4

1.3

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

3.96

4.29

2.7

1.4

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

256

1974

1.33

4.25

2.6

2.2

29.98

61.73

u/l

0.71

218

1672

(3047189) Immunofixation for 24 hour Urine

3.05

4.24

2.1

1.1

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

103

676

1.54

4.19

1.4

1.3

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

605

1.57

4.17

3.1

2.3

183.73

178.81

0.22

571

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

383

1.71

4.08

1.4

1.5

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

2.64

4.06

5.8

5.4

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

119

814

1.48

4.00

2.0

1.6

1.54

1.51

g/l

0.12

101

705

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

2.82

3.95

1.4

2.9

—

(3049717) Cytology report of Urine Cyto stain

582

1.56

3.93

2.5

1.8

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

380

1.70

3.92

1.8

1.7

0.74

0.79

g/l

0.11

288

(3026493) Urate [Moles/volume] in Serum or Plasma

683

5944

1.19

3.91

2.8

2.2

1917.16

4982.94

umol/l

2.27

605

5203

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

176

1303

1.37

3.84

4.4

4.0

5.14

5.17

kpa

0.26

170

1236

(21494890) Protein electrophoresis panel - 24 hour Urine

159

2.09

3.82

1.8

1.2

—

(40765096) Chromosome analysis panel by Banding

4.30

3.81

1.2

1.0

—

(3009343) pH of Capillary blood

174

1289

1.37

3.79

4.5

4.0

7.41

0.04

138

(40763324) Parainfluenza virus 1 RNA [Presence] in Isolate by NAA with probe detection

215

1.92

3.77

1.7

1.4

—

(40763470) Parainfluenza virus 4 RNA [Presence] in Isolate by NAA with probe detection

215

1.92

3.77

1.7

1.4

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

297

2376

1.28

3.77

1.4

—

(3037522) Nuclear Ab [Titer] in Serum

425

3546

1.23

3.74

1.4

1.3

419.02

566.31

titre

1.49

773

(3003181) Sodium [Moles/volume] in Urine

386

1.67

3.72

1.4

64.37

64.19

mmol/l

0.01

313

(3029937) Albumin [Presence] in Urine by Test strip

707

6199

1.19

3.70

4.2

4.0

0.00

estimate

0.88

293

2020

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

167

1244

1.36

3.53

4.5

4.0

2.47

1.70

mmol/l

1.99

135

922

(3021879) Hepatitis B virus core Ab [Presence] in Serum

196

1497

1.33

3.52

1.4

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

464

3936

1.21

3.47

1.9

1.8

—

(3020876) Protein [Mass/time] in 24 hour Urine

201

1.90

3.43

3.6

2.0

0.89

1.91

g/24h

1.52

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

230

1803

1.30

3.43

3.4

2.3

64.16

68.26

ml/min/173m2

0.86

684

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

427

1.61

3.41

1.4

1.3

292.72

247.36

u/ml

0.63

259

(3021960) Folate [Moles/volume] in Serum or Plasma

607

5289

1.19

3.39

1.6

1.5

21.87

21.05

nmol/l

0.23

543

4486

(40768441) Liver Pathology biopsy report

133

2.12

3.39

1.0

1.4

—

(3004269) Kappa light chains [Mass/time] in 24 hour Urine

5.73

3.34

6.3

1.1

—

(3024928) Oxygen saturation in Venous blood

422

1.60

3.32

10.5

3.0

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

391

1.62

3.32

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

391

1.62

3.32

1.3

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

240

3000

0.78

3.31

4.5

4.6

32.55

32.70

0.07

162

2055

(3017732) Neutrophils [#/volume] in Blood

213

1665

1.30

3.26

2.7

3.91

5.09

e9/l

2.28

181

1355

(3001019) Free T4 and TSH panel - Serum or Plasma

188

1446

1.32

3.24

2.2

1.7

—

(3004451) EKG impression Narrative

2.28

3.19

1.2

1.4

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

130

2.09

3.18

1.4

1.7

—

(3016018) Differential panel - Cerebral spinal fluid

236

1.79

3.17

1.6

1.3

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

2.32

3.17

3.2

2.4

40.77

47.57

1.04

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

152

1137

1.36

3.16

1.5

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

114

816

1.41

3.10

1.8

1.6

337.26

306.20

mu/l

0.39

107

732

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

5.01

3.05

1.6

1.2

—

(3035880) pH of Pleural fluid

2.51

3.04

1.2

1.4

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

750

6705

1.16

3.02

1.8

1.6

1.33

1.38

mmol/l

0.86

626

5654

(3006184) Hemoglobin [Mass/volume] in Capillary blood

457

1.54

3.01

2.4

2.1

122.53

131.25

g/l

1.86

330

(3024354) Oxygen [Partial pressure] in Venous blood

201

1579

1.29

2.99

7.4

3.1

4.92

4.62

kpa

0.85

193

1530

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

10.01

2.98

9.6

1.0

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

532

4634

1.18

2.97

5.2

3.6

2.20

1.81

ug/l

1.67

477

4160

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

165

1263

1.32

2.96

2.5

2.4

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

2.64

2.96

1.1

1.3

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

581

5105

1.17

2.91

1.6

450.75

39953429.70

pmol/l

5.05

465

4255

(4062490) Immunoglobulin typing, IgG

243

1.74

2.90

1.7

1.4

—

(3011648) Oxygen content in Venous blood

170

1.89

2.90

17.2

2.4

10.08

11.32

0.84

170

(40758292) HTLV I+II Ab panel - Serum

5.39

2.87

2.0

1.3

—

(3023419) Bacteria identified in Sputum by Culture

328

1.63

2.87

3.7

2.7

—

(3024139) IgG subclass 3 [Mass/volume] in Serum

245

1.72

2.83

1.7

1.4

0.33

0.38

g/l

0.46

171

(3028192) IgG subclass 2 [Mass/volume] in Serum

245

1.72

2.83

1.7

1.4

2.66

2.84

g/l

0.17

170

(3036489) Thrombin time

111

805

1.39

2.82

2.7

2.0

21.44

20.95

0.43

688

(3027135) IgG subclass 1 [Mass/volume] in Serum

246

1.72

2.79

1.7

1.4

7.28

6.81

g/l

0.33

171

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

680

6072

1.16

2.76

3.1

3.0

1454.83

1190.80

ng/l

0.45

575

5122

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

2.32

2.74

1.1

—

(3000494) Fungus identified in Specimen by Culture

325

2731

1.21

2.70

1.7

1.4

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

205

1.77

2.65

1.3

1.2

—

(4281824) Cell count and differential, peritoneal fluid

140

1.94

2.65

1.1

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

125

939

1.35

2.59

6.8

2.6

0.65

0.05

125

932

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

207

1.75

2.57

1.4

1.5

—

(3026389) Candida sp identified in Specimen by Organism specific culture

346

1.57

2.57

1.3

—

(3027401) Testosterone Free/Testosterone.total in Serum or Plasma

7.15

2.55

1.0

1.1

1.42

1.26

—

(3020891) Body temperature

108

796

1.37

2.53

4.7

4.4

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

636

1.41

2.50

1.4

320.29

312.25

ug/g

0.15

347

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

219

1.70

2.41

2.5

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

111

1.99

2.35

1.5

1.7

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

2.31

1.3

1.2

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

2.19

2.31

3.2

1.4

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

2.19

2.31

3.2

1.4

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

372

1.52

2.30

1.3

1.5

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

200

1.71

2.28

1.3

1.1

—

(3009508) Creatinine [Moles/volume] in Urine

810

7411

1.13

2.24

3.2

7.10

7.27

mmol/l

0.57

686

6295

(3015736) pH of Urine

1021

9471

1.12

2.24

3.4

3.3

5.89

5.90

0.00

710

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

374

3241

1.18

2.23

1.7

1.6

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

172

1.75

2.20

2.5

1.4

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

195

1.70

2.19

2.4

1.4

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

2.51

2.18

1.0

1.1

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

108

1.95

2.15

1.5

1.3

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

2.37

2.12

1.4

1.1

—

(3032868) Hemoglobin electrophoresis panel in Blood

3.21

2.09

1.8

1.5

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

237

1.61

2.07

1.4

1.2

1.96

2.69

ug/l

0.67

209

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

2.08

2.06

1.0

1.2

124.06

112.59

0.99

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

198

1631

1.23

2.05

1.3

68.57

46.71

au/ml

0.53

(43055514) Macroprolactin [Presence] in Serum or Plasma

2.33

2.04

1.3

1.4

—

(3007566) Smooth muscle Ab [Titer] in Serum

645

1.36

2.02

1.2

80.00

89.83

titre

0.24

(3043410) Blood group antigens tested for on Red Blood Cells

2.41

2.02

3.4

1.2

—

(3048689) Calprotectin [Mass/mass] in Stool

354

3081

1.17

2.02

2.5

2.3

119.32

114.04

ug/g

0.14

278

2439

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

2.51

2.01

1.1

1.5

62.97

110.46

ng/l

1.49

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

100

759

1.33

2.00

1.6

1.7

0.25

0.23

g/l

1.51

713

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

2.82

2.00

1.4

1.0

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

2.82

2.00

1.4

1.0

—

(3020393) Adenovirus Ag [Presence] in Stool

2.82

2.00

1.6

1.5

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

2.82

2.00

1.4

1.0

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

2.15

1.98

1.2

1.3

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

633

5749

1.13

1.96

1.3

1.93

1.77

u/ml

0.14

170

1564

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

105

1.91

1.95

1.6

1.3

—

(3037121) Protein [Mass/volume] in Urine

702

1.34

1.94

4.6

3.0

0.18

0.35

g/l

2.54

232

(3044007) Cell count panel - Peritoneal fluid

2.57

1.94

1.8

2.8

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

522

4688

1.14

1.93

1.4

—

(21494434) Karyotype in Bone marrow

135

1.78

1.91

1.3

1.2

—

(3025941) Bacteria identified in Stool by Culture

168

1372

1.24

1.90

1.3

1.2

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

150

1.74

1.90

2.7

1.3

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

150

1.74

1.90

2.7

1.3

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

150

1.74

1.90

2.7

1.3

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

418

3709

1.15

1.85

4.3

3.5

22.43

24.13

1.32

214

1632

(40768443) Skin Pathology biopsy report

116

910

1.29

1.85

1.2

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

2.40

1.85

2.3

6.62

7.63

mmol/l

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

101

779

1.31

1.83

1.6

1.7

1.19

1.18

g/l

0.12

729

(3021162) Amylase [Enzymatic activity/volume] in Specimen

4.17

1.82

3.8

3.0

315.60

503.83

u/l

—

(3030313) Adrenal Ab [Titer] in Serum

4.17

1.82

1.0

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

213

1794

1.20

1.80

2.4

12.58

26.72

au/ml

3.56

131

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

538

1.37

1.80

1.5

1.3

41.93

26.36

e6/l

0.33

422

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

539

1.36

1.78

1.5

1.3

1058.45

1413.99

e6/l

0.18

446

(3016750) Collection duration of Urine

124

1.78

1.75

1.7

2.2

492.12

501.32

min

0.22

(3022475) Manganese [Moles/volume] in Blood

3.85

1.71

1.2

1.0

—

(3003327) Ova and parasites identified in Stool by Light microscopy

103

805

1.29

1.71

1.6

1.8

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

1.92

1.69

1.2

1.3

—

(3050129) First trimester maternal screen panel - Serum or Plasma

634

0.69

1.68

1.4

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

967

0.75

1.68

1.5

—

(3008536) Aspergillus sp Ab [Presence] in Serum

2.80

1.65

4.0

2.0

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

2.25

1.63

4.0

2.5

—

(3019309) Folate [Moles/volume] in Red Blood Cells

469

4232

1.13

1.62

1.8

1.7

1196.39

1167.35

nmol/l

0.27

371

3209

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

1035

9748

1.10

1.59

2.0

1.9

95.49

97.36

pmol/l

0.55

522

4833

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

761

1.28

1.59

2.3

1.4

10.15

10.36

g/l

0.16

659

(3015171) Extractable nuclear Ab [Units/volume] in Serum

132

1078

1.24

1.55

1.4

1.3

2.42

0.95

u/ml

0.30

101

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

157

0.44

1.54

1.3

—

(3044290) Cell count panel - Cerebral spinal fluid

485

1.35

1.52

1.5

1.3

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

3.34

1.52

7.8

3.9

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

138

1137

1.22

1.50

1.8

1.6

—

(21494755) Public health laboratory ask at order entry panel

202

2351

0.85

1.47

1.3

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

734

1.28

1.47

1.1

2.13

5.72

u/ml

1.46

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

296

2610

1.15

1.47

3.1

2.6

0.76

0.70

ug/l

0.78

207

1647

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

2.23

1.46

1.1

1.2

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

179

1.57

1.45

2.4

2.5

—

(3052592) Norovirus Ag [Presence] in Stool

2.37

1.45

1.4

1.3

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

102

816

1.26

1.45

2.3

1.4

—

(3022313) Gas panel - Capillary blood

119

969

1.24

1.45

4.7

4.1

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

1011

0.78

1.45

1.4

1.5

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

102

817

1.26

1.44

2.3

1.4

7.29

7.42

g/l

0.34

721

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

102

817

1.26

1.44

2.3

1.4

3.60

3.70

g/l

0.34

721

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

2.73

1.43

23.2

10.7

5.05

5.73

mmol/l

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

379

1.38

1.42

1.1

—

(3033799) Differential panel - Peritoneal fluid

2.25

1.40

2.7

2.1

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

563

0.71

1.39

1.3

1.5

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

591

1.29

1.37

1.1

1.2

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

574

1.30

1.36

1.3

1.2

14.91

45.09

u/ml

—

(36305075) Vedolizumab [Mass/volume] in Serum or Plasma by Immunoassay

2.94

1.36

7.8

3.6

22.60

21.65

mg/l

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

1.83

1.35

1.7

1.4

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

1.83

1.35

1.7

1.4

—

(3045414) Leukocytes [Presence] in Urine

1078

0.79

1.35

1.9

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

1644

15872

1.08

1.34

3.2

3.0

—

(3051651) Icteric interference index of Serum or Plasma

105

1.72

1.33

8.0

4.2

—

(1002224) Polysomnography panel

124

1030

1.21

1.28

1.0

1.1

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

2.29

1.26

1.5

1.8

12.18

10.77

g/l

—

(3023410) Appearance of Cerebral spinal fluid

236

1.45

1.24

1.7

1.4

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

1.86

1.24

1.1

—

(3012516) Albumin [Mass/volume] in Urine

736

6903

1.09

1.21

3.3

3.2

1054.71

283.88

mg/l

1.95

458

4201

(3051611) Lipemic interference index of Serum or Plasma

205

1.47

1.19

6.1

3.4

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

994

0.80

1.19

2.1

1.7

3.75

4.17

mg/l

0.17

727

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

489

1.29

1.18

1.4

1.3

—

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

0.00

1.16

0.0

2.3

—

43.02

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

223

0.58

1.15

1.2

1.1

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

130

1532

0.84

1.15

1.3

1.4

—

(3015183) Erythrocyte sedimentation rate

126

1.59

1.14

1.3

1.2

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

2.34

1.12

1.1

1.2

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

2.38

1.09

1.0

1.1

—

(3017509) Phencyclidine [Presence] in Urine

2.38

1.09

1.2

1.1

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

2301

22595

1.09

1.08

5.8

5.6

39.30

39.44

mmol/mol

0.34

2150

21026

(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma

1.64

1.03

3.8

1.6

182.69

189.32

u/l

0.17

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

465

1.27

1.02

1.1

1.2

—

(3000093) Morphology [Interpretation] in Blood Narrative

163

1.48

1.01

1.3

1.1

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

107

1.59

0.99

2.2

1.2

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

2.18

0.98

2.2

1.7

—

(3005322) IgE [Units/volume] in Serum or Plasma

188

1661

1.14

0.98

1.3

110.58

201.38

u/ml

2.50

173

1537

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.77

0.94

1.1

—

(3000330) Specific gravity of Urine by Test strip

100

1180

0.84

0.94

3.4

3.2

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

753

1.20

0.93

1.4

1.3

12.74

41.24

u/ml

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

753

1.20

0.93

2.2

1.7

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

819

1.19

0.91

2.6

1.7

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

375

1.28

0.91

1.1

1.0

2.12

2.94

u/ml

0.41

171

(36660697) Celiac disease serology panel - Serum

231

2081

1.12

0.90

1.2

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

185

1.41

0.89

1.5

2.3

2.00

2.10

u/field

—

(40761535) Cells panel - Urine sediment

171

1928

0.88

0.89

3.9

3.4

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

675

1.21

0.88

1.2

1.3

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

767

1.19

0.88

2.4

1.4

2.80

2.92

g/l

0.64

671

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

415

0.74

0.87

1.7

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

1.79

0.87

4.6

1.5

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

1.79

0.87

4.6

1.5

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

1.79

0.87

4.6

1.5

—

(3020682) Albumin/Creatinine [Ratio] in Urine

764

7269

1.07

0.87

3.9

3.8

11.39

10.47

mg/mmol

0.10

462

4420

(3014148) Varicella zoster virus Ab [Titer] in Serum

290

1.31

0.86

1.2

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

194

1737

1.13

0.85

1.3

1.2

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

1.78

0.84

1.1

1.0

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

214

1.36

0.82

1.2

2.30

2.09

u/ml

0.03

122

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

1.88

0.81

1.0

1.2

—

(3003740) Influenza virus B Ag [Presence] in Specimen

382

1.26

0.81

1.2

1.1

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

1.58

0.81

1.2

1.0

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

391

1.26

0.81

1.3

1.2

1.67

3.03

u/ml

0.78

120

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

0.00

0.79

0.0

1.0

—

0.01

—

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

0.00

0.79

0.0

1.0

—

0.22

—

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

148

0.61

0.79

20.0

12.3

709.67

829.16

nmol/l

—

142

(3002523) Influenza virus A Ag [Presence] in Specimen

384

1.25

0.78

1.2

1.1

—

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

151

0.59

0.78

36.9

16.9

1097.00

1486.34

nmol/l

—

146

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

0.00

0.77

0.0

1.2

—

(4094501) Cardiovascular stress test using bicycle ergometer

693

0.82

0.77

1.0

1.1

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

376

1.25

0.77

1.1

—

(4146454) Self-monitoring of blood glucose

257

0.70

0.77

2.4

2.8

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

386

1.25

0.75

1.3

1.2

5.48

5.46

u/ml

0.00

154

(3044941) Cell count panel - Synovial fluid

386

1.25

0.75

1.4

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

2412

24408

0.93

0.75

4.4

1.47

1.51

mmol/l

4.55

2243

22676

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

1.64

0.75

1.1

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

2.09

0.74

5.0

8.8

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

2.09

0.74

4.8

5.9

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

2.09

0.74

2.4

3.0

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

514

0.79

0.74

1.3

1.4

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

116

1.47

0.74

1.3

1.1

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

513

0.80

0.73

1.3

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

513

0.80

0.73

1.3

1.4

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

272

1.29

0.72

1.6

1.3

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

512

0.80

0.72

1.3

1.4

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

142

1.41

0.72

1.1

1.15

1.05

u/l

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

185

1.35

0.72

4.5

4.1

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

831

1.16

0.71

1.6

1.9

—

(3021788) Differential panel - Synovial fluid

435

1.22

0.71

1.6

1.5

—

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

1.92

0.70

1.2

3.4

—

16.63

—

(3004775) Volume in Urine collected for unspecified duration

177

1.36

0.70

1.9

2.4

615.06

625.38

0.03

124

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

336

1.25

0.70

1.2

1.1

—

(3003338) MCHC [Mass/volume]

2140

21070

1.06

0.70

24.9

14.8

332.18

332.12

g/l

0.12

2128

20930

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

142

0.63

0.69

1.3

1.4

—

658.46

—

(3035320) C reactive protein [Mass/volume] in Body fluid

169

1.36

0.69

1.9

2.4

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

216

0.69

1.3

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

216

0.69

1.3

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

216

0.69

1.3

1.1

—

(3024932) HLA-DR beta [Type]

1.64

0.68

1.0

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

239

2597

0.91

0.68

1.9

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

118

0.59

0.67

1.1

1.5

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

215

0.70

0.67

1.3

1.1

—

(3024263) Appearance of Synovial fluid

121

0.58

0.67

1.6

1.4

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

1.63

0.66

1.1

1.2

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

136

1.40

0.66

1.4

1.2

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

1.49

0.66

1.1

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

211

2303

0.91

0.66

1.8

1.9

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

223

1.30

0.66

1.2

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

214

0.70

0.66

1.3

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

214

0.70

0.66

1.3

1.1

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

1.54

0.65

1.0

—

(3014271) Vancomycin [Susceptibility]

103

1.46

0.65

2.5

2.8

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

1.73

0.64

1.6

2.5

0.80

0.76

u/field

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

1.73

0.64

1.4

1.1

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

2432

24568

0.94

0.62

4.5

4.4

4.71

4.76

mmol/l

1.76

2276

22941

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

1.63

0.62

1.0

1.7

—

(3024471) HLA-A [Type]

1.59

0.61

1.0

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

1.60

0.61

1.1

1.2

—

(40768446) Kidney Pathology biopsy report

1.48

0.60

1.6

—

(3036312) Salmon IgE Ab [Units/volume] in Serum

0.00

0.60

0.0

1.0

—

5.10

—

(3028717) Thiamine [Mass/volume] in Blood

0.00

0.60

0.0

1.2

—

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

0.00

0.59

0.0

1.0

—

0.03

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

696

1.15

0.59

1.4

1.3

3.63

5.92

u/ml

0.61

115

(3019150) Specific gravity of Urine by Refractometry

548

5230

1.06

0.58

4.4

4.0

1.02

kg/l

0.06

760

(3042847) Granulocytes/100 leukocytes in Cerebral spinal fluid

0.00

0.58

0.0

1.2

—

30.43

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

442

0.81

0.58

1.4

1.5

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

114

0.61

0.58

1.0

1.1

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

149

1.34

0.57

1.0

1.1

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

319

1.23

0.57

1.2

1.1

—

(40760548) Muscle specific receptor tyrosine kinase Ab [Units/volume] in Serum by Immunoassay

1.46

0.56

1.0

1.1

—

(3045424) Erythrocytes [Presence] in Urine

385

0.80

0.56

1.5

1.6

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

2331

23557

0.95

0.55

3.9

1.30

1.28

mmol/l

0.70

2152

21692

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

284

1.24

0.55

1.2

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

159

1.32

0.55

1.2

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

266

1.24

0.55

1.6

1.3

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

148

0.67

0.55

1.1

0.31

1.39

u/ml

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

683

1.15

0.54

2.6

1.4

0.71

0.39

g/l

0.25

583

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

350

0.80

0.54

1.5

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

267

1.24

0.54

1.6

1.3

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

1.54

0.53

1.2

1.3

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

480

0.83

0.53

1.5

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

770

1.13

0.52

1.7

1.5

0.44

0.13

iu/ml

0.33

153

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

210

2261

0.92

0.52

1.6

1.7

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

260

2775

0.93

0.51

1.6

1.7

1.38

1.44

0.72

224

2467

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

161

1.31

0.51

1.2

—

(3014051) Protein [Presence] in Urine by Test strip

629

0.86

0.51

2.1

2.5

—

(3011288) Drugs identified in Urine by Screen method

543

0.84

0.51

1.9

2.8

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

687

1.14

0.51

1.4

1.3

1.78

7.18

u/ml

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

1.46

0.50

2.3

1.1

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

291

0.79

0.50

1.0

1.1

0.18

0.29

u/ml

—

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

101

1.39

0.49

3.6

1.9

22.44

96.61

ug/l

0.47

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

111

1002

1.11

0.49

1.3

1.4

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

362

1.19

0.49

1.2

1.1

124.79

117.71

0.67

326

(3019897) Erythrocyte distribution width [Ratio] by Automated count

353

1.19

0.49

2.6

13.50

13.19

0.71

348

(3017315) Amylase [Enzymatic activity/volume] in Urine

119

1.35

0.48

1.0

1.2

173.00

334.96

u/l

0.95

106

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

181

1.27

0.48

1.2

1.1

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

130

1186

1.10

0.48

1.6

1.7

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

162

1494

1.09

0.47

1.7

1.8

—

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

263

1.22

0.47

1.5

1.8

—

1706.67

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

263

1.22

0.47

1.3

1.0

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

430

0.84

0.47

1.3

1.4

—

(3006576) Bicarbonate [Moles/volume] in Blood

1.47

0.47

11.8

6.9

25.13

25.30

mmol/l

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

384

1.17

0.45

3.1

3.2

0.85

0.81

nmol/l

0.17

287

(3028772) Osteocalcin [Mass/volume] in Serum or Plasma

121

0.66

0.45

2.3

2.7

45862.50

38319.36

ug/l

—

121

(3005033) Fetal Nuchal fold Thickness US

428

0.84

0.45

1.3

1.4

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

147

1.29

0.45

1.6

1.5

—

(3042733) HLA Ab [Presence] in Serum

1.45

0.44

4.6

4.8

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

2478

24964

0.95

0.43

5.0

4.9

2.80

2.82

mmol/l

0.61

2304

23203

(3022621) pH of Urine by Test strip

171

1589

1.08

0.43

3.1

2.9

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

350

1.17

0.42

1.7

1.4

33.63

28.41

u/l

0.38

265

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

594

1.13

0.42

1.3

1.4

—

24.76

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

1.40

0.42

2.5

1.3

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

718

1.12

0.41

1.2

1.1

—

(3018001) Oat IgE Ab [Units/volume] in Serum

0.00

0.41

0.0

1.0

—

0.07

—

(3034552) Adenosine deaminase [Enzymatic activity/volume] in Cerebral spinal fluid

0.00

0.41

0.0

1.0

—

(36305790) Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay

0.00

0.41

0.0

2.7

—

4.09

—

(3007542) Rye IgE Ab [Units/volume] in Serum

0.00

0.41

0.0

1.1

—

0.15

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

0.00

0.41

0.0

1.1

—

(46235689) Lupus anticoagulant aPTT, dRVVT and PT screening panel W Reflex

268

1.20

0.40

2.2

—

(3024869) Neuronal Ab [Presence] in Serum

1.47

0.40

1.0

1.1

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

141

1.28

0.40

1.0

1.1

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

422

0.85

0.40

1.0

1.1

0.90

1.16

u/ml

0.16

189

(3009871) Measles virus Ab [Titer] in Serum

1.37

0.40

1.8

1.7

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

1.43

0.39

3.2

2.3

—

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

0.00

0.39

0.0

1.0

—

2.17

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

2418

23998

1.04

0.38

4.7

4.5

5.91

5.87

mmol/l

0.67

2249

22034

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

142

1.27

0.38

1.0

1.1

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

345

0.84

0.38

1.2

1.5

—

(4200892) Spirometry reversibility

164

1752

0.93

0.37

1.4

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

1.35

0.37

1.0

1.2

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

1.39

0.37

1.2

1.1

—

(3028433) Virus identified in Specimen by Culture

1.29

0.36

1.1

1.2

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

146

0.75

0.36

1.2

1.4

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

171

1.23

0.35

1.6

1.5

78.38

78.29

umol/l

0.00

171

(3004716) Salmonella sp identified in Stool by Organism specific culture

121

1305

0.92

0.35

1.4

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

1.43

0.35

1.2

1.1

—

(42529406) Shigella sp [Presence] in Stool by Culture

727

1.10

0.35

1.2

—

(3017569) Oxygen content in Arterial blood

1.32

0.33

1.5

2.0

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

127

1.26

0.33

1.3

1.4

157.75

230.42

pmol/l

0.47

127

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

606

1.11

0.33

1.9

1.4

0.05

0.01

g/l

0.35

553

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

275

1.17

0.32

1.5

1.6

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

433

0.88

0.31

1.1

3.99

4.45

u/ml

0.13

230

(3023430) Cat dander IgE Ab [Units/volume] in Serum

315

0.86

0.30

1.1

0.74

3.56

u/ml

—

127

(3028679) Herpes simplex virus Ab [Presence] in Serum

120

1.25

0.30

1.2

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

286

2975

0.96

0.28

7.8

6.0

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

103

1.26

0.28

1.7

1.8

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

565

1.10

0.28

1.9

1.4

0.00

g/l

-0.00

514

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

117

0.77

0.27

1.8

6.4

—

53.91

—

(3008898) HLA-B27 [Presence]

923

1.08

0.27

1.1

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

547

1.10

0.27

2.7

2.3

89.64

103.44

ug/min

0.08

334

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

395

0.88

0.26

1.1

37.75

1509.48

iu/ml

—

(3036180) Methadone [Presence] in Urine

1.28

0.26

2.6

1.9

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

171

0.82

0.26

1.0

1.1

5.44

11.38

iu/ml

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

1.30

0.26

1.8

1.3

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

1.30

0.26

1.8

1.3

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

559

1.09

0.25

1.9

1.4

0.00

g/l

-0.00

513

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

123

1.22

0.25

1.3

1.1

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

714

1.08

0.25

1.2

1.1

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

217

1.15

0.24

1.9

1.4

32.12

33.16

0.05

135

(3034274) Bile acid [Moles/volume] in Serum --fasting

297

0.87

0.24

1.2

2.2

6.53

5.26

umol/l

0.22

208

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

0.71

0.24

3.5

2.7

32.00

29.04

umol/l

—

(3000492) Spirometry study

224

2330

0.96

0.24

1.5

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

265

1.13

0.23

1.6

2.3

38.78

24.79

mg/l

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

1.32

0.23

3.8

5.6

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

453

0.90

0.23

1.7

1.3

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

456

4677

0.97

0.23

1.3

36.34

32.77

iu/ml

0.15

148

1495

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

190

1.16

0.23

1.2

1.1

38.49

33.23

mg/l

0.15

157

(3048879) Bone marrow aspiration report

1.28

0.23

1.2

1.7

—

(3029396) Erythrocyte agglutination [Presence] in Blood

1.28

0.23

1.2

3.5

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

348

0.89

0.23

1.0

1.1

1.71

2.89

u/ml

0.77

167

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

718

1.07

0.22

1.4

—

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

0.76

0.22

1.6

1.5

—

1182955.00

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

0.74

0.22

1.1

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

238

1.14

0.22

2.2

—

(40757373) Influenza virus identified in Isolate

1.19

0.21

1.0

1.6

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

0.00

0.21

0.0

1.0

—

(3038864) risperiDONE [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

1.8

—

10.08

—

(3029856) Leukocytes [#/volume] in Peritoneal dialysis fluid

0.00

0.21

0.0

5.7

—

285.00

—

(3007463) Buprenorphine [Presence] in Urine

0.00

0.21

0.0

4.5

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

258

1.13

0.21

1.7

1.4

—

(3010937) Rubella virus Ab [Presence] in Serum

0.00

0.21

0.0

1.1

—

(3007700) Barley IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.1

—

0.12

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

0.00

0.21

0.0

6.7

—

(3042951) Complement C1q Ab [Units/volume] in Serum

0.00

0.21

0.0

1.2

—

24.44

—

(3034426) Prothrombin time (PT)

1.24

0.21

1.2

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

1.24

0.21

1.4

1.8

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

383

1.10

0.20

1.2

1.1

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

145

1.17

0.20

1.4

1.3

—

(3015956) Eosinophils/100 leukocytes in Blood by Manual count

0.00

0.20

0.0

1.4

—

2.68

—

(3027901) Hemoglobin [Mass/volume] in Arterial cord blood

0.00

0.20

0.0

1.0

—

171.50

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

878

1.06

0.20

1.8

1.9

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

259

1.12

0.20

1.7

1.4

—

(3019977) pH of Arterial blood

1.21

0.19

1.5

2.9

7.41

7.43

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

261

1.11

0.18

1.7

1.4

—

(3020650) Glucose [Presence] in Urine

1.17

0.17

1.0

1.7

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

484

1.08

0.17

2.0

2.1

0.99

0.78

nmol/l

1.49

398

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

205

0.88

0.17

1.2

1.4

1.45

1.41

nmol/l

0.07

186

(4034850) Laboratory test

846

1.05

0.16

12.3

8.8

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

292

1.10

0.16

1.8

1.5

67.58

59.86

0.54

181

(3000034) Microalbumin [Mass/volume] in Urine

225

0.89

0.16

4.5

3.0

45.98

23.13

mg/l

0.36

157

(3023511) Choriogonadotropin [Units/volume] in Urine

453

0.93

0.16

1.3

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

192

1860

1.03

0.16

1.9

2.3

7.99

7.18

ug/l

0.15

165

1627

(3039162) Centromere protein B Ab [Units/volume] in Serum

332

1.09

0.15

1.3

51.90

37.35

u/ml

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

491

0.94

0.14

1.0

1.1

1.75

2.75

u/ml

0.65

261

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

101

969

1.04

0.14

1.7

1.6

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

421

1.07

0.14

1.2

—

(3044927) Protein electrophoresis panel - Urine

237

1.10

0.14

1.2

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

237

1.10

0.14

1.1

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

647

1.05

0.13

2.1

1.4

38.38

38.00

g/l

0.21

551

(3029634) Reagin Ab [Titer] in Serum by VDRL

325

1.08

0.13

1.6

1.9

—

4.00

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

443

4502

0.98

0.13

1.3

15.03

11.91

u/ml

0.35

168

1802

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

107

0.84

0.13

1.1

1.2

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

550

1.06

0.12

1.3

1.2

15.01

3.77

u/ml

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

171

1.11

0.12

1.1

1.0

—

(3004616) Nuclear Ab [Presence] in Serum

326

1.07

0.12

1.4

1.2

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

114

1.14

0.11

1.1

1.0

—

(3019832) Treponema pallidum Ab [Presence] in Serum

207

2023

1.03

0.11

1.6

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

167

0.90

0.10

1.1

—

(3044242) Glucose [Moles/volume] in Arterial blood

1.15

0.10

1.1

1.9

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

378

1.06

0.10

1.2

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

156

0.90

0.10

1.1

1.2

—

(3032057) Clostridioides difficile [Presence] in Stool

1.14

0.10

1.8

1.9

—

(3002619) Bacteria identified in Specimen by Culture

1.09

0.09

1.0

1.2

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

145

1.10

0.09

1.1

1.2

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

155

1.10

0.09

1.1

—

(1761868) Lipid panel - Serum or Plasma

895

8886

1.01

0.08

2.8

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

756

1.03

0.08

1.4

1.3

235.12

214.19

miu/ml

0.19

373

(3035933) Granulocytes/100 leukocytes in Blood

1.03

0.07

1.4

1.5

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

288

2841

1.02

0.07

1.6

1.7

—

(3025130) Human papilloma virus identified in Specimen

368

0.95

0.07

1.7

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

174

0.92

0.07

1.0

35.14

51.88

ng/l

0.66

112

(3020874) Milk IgE Ab [Units/volume] in Serum

153

0.91

0.07

1.0

1.1

1.35

1.13

u/ml

—

(3036071) Salmonella sp Ab [Titer] in Serum

0.82

0.07

1.0

1.1

—

(3051593) INR in Capillary blood by Coagulation assay

101

0.89

0.06

9.9

10.8

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

554

5580

0.99

0.06

3.9

3.6

—

(3027944) Amphetamines [Presence] in Urine

781

1.03

0.05

1.6

1.9

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

516

0.97

0.05

2.6

3.5

38.44

23.48

mg/l

0.98

318

(3032773) Endomysium IgG Ab [Titer] in Serum

218

1.06

0.05

1.0

1.1

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

110

1.09

0.05

1.2

1.1

1737.42

1592.09

miu/ml

0.17

110

(3006462) Nitrate [Presence] in Urine

110

1.09

0.05

2.1

3.3

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

171

0.94

0.05

1.0

875.09

723.72

ng/l

0.41

109

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

416

1.03

0.05

2.0

1.7

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

170

0.94

0.04

1.0

283.73

367.81

ng/l

0.61

112

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

111

1.08

0.04

1.0

1.1

—

(3000764) Benzodiazepines [Presence] in Urine

786

1.02

0.03

1.6

2.0

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

138

1395

0.99

0.03

1.0

1.1

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

201

1.05

0.03

1.2

1.0

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

172

1.05

0.02

1.6

1.3

1.59

1.58

g/l

0.06

172

(3010726) Horse dander IgE Ab [Units/volume] in Serum

389

0.98

0.02

1.1

0.78

1.53

u/ml

0.49

199

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

198

0.96

0.02

1.7

1.2

—

(3027008) Opiates [Presence] in Urine

790

1.01

0.02

1.6

2.0

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

1.08

0.02

1.8

2.5

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

123

1.06

0.01

1.7

1.4

—

(3028707) Methadone [Presence] in Urine by Screen method

348

0.98

0.01

2.0

2.6

—

(3006653) Thiamine [Moles/volume] in Blood

127

0.94

0.01

1.1

1.3

123.67

137.73

nmol/l

1.35

127

(1761482) Bacteria [#/volume] in Urine by Culture

548

0.99

0.01

3.8

4.1

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

622

1.01

0.01

1.4

1.3

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

694

1.01

0.00

1.3

1.1

—

(3028300) Cannabinoids [Presence] in Urine

794

1.01

0.00

1.6

2.0

—

(44813793) Dust mix specific IgE antibody measurement

175

0.97

0.00

1.1

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

385

0.99

0.00

1.1

—

(3039443) Prostate specific Ag panel - Serum or Plasma

289

1.00

0.00

1.3

1.6

—

(3000475) Leukocytes [#/volume] in Synovial fluid

579

1.00

0.00

1.7

1.6

15436.00

10549.33

e6/l

0.47

425

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

206

1.02

0.00

1.5

1.4

1.00

0.96

g/l

0.33

206

(3015076) Soybean IgE Ab [Units/volume] in Serum

128

1.02

0.00

1.1

0.09

2.79

u/ml

—

(3016879) Cocaine [Presence] in Urine

726

1.01

0.00

1.6

2.0

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

623

1.00

0.00

1.7

2.0

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

183

0.98

0.00

1.4

1.6

0.72

1.32

promille

0.90

143

(3019420) Tryptase [Mass/volume] in Serum or Plasma

133

0.98

0.00

1.6

1.5

7.62

8.04

ug/l

0.09

111

(3011325) HIV 1+2 Ab [Presence] in Serum

0.00

0.0

1.0

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.02

0.00

1.2

1.1

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

1.02

0.00

1.2

3.4

—

(3034614) HLA Ag [Interpretation]

0.00

0.0

1.1

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

0.90

0.00

1.4

1.1

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.91

0.00

1.2

1.1

—

(3018834) Bilirubin.total [Presence] in Urine by Test strip

0.00

0.0

1.2

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

1.02

0.00

1.2

3.4

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.3

—

(3027696) Helicobacter pylori Ab [Titer] in Serum

0.00

-0.00

0.0

1.2

—

1228.00

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

0.97

-0.00

1.3

2.6

—

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

0.00

-0.00

0.0

1.0

—

(3029612) Listeria sp Ab [Titer] in Serum

0.00

-0.00

0.0

1.2

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.0

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

-0.00

0.0

2.0

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.1

—

690.46

—

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

0.00

-0.00

0.0

4.3

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

-0.00

0.0

2.0

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

0.90

-0.00

1.0

1.4

7.47

8.63

ug/l

—

(3041806) Other cells [#/volume] in Blood by Manual count

0.98

-0.00

1.2

1.5

—

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

-0.00

0.0

1.0

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

1.00

-0.00

1.1

1.2

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

0.93

-0.00

1.1

1.3

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

200

1.00

-0.00

1.4

8.14

8.40

mmol/l

0.10

194

(3029075) Extractable nuclear Ab panel - Serum

0.96

-0.00

1.0

1.1

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

-0.00

0.0

2.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

-0.00

0.0

1.0

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

0.00

-0.00

0.0

4.3

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

0.00

-0.00

0.0

1.0

—

(3017400) Magnesium [Moles/volume] in Urine

0.00

-0.00

0.0

1.0

—

2.49

—

(3040893) Potassium [Moles/volume] in Capillary blood

0.00

-0.00

0.0

2.4

—

4.51

—

(3038385) Creatinine [Moles/volume] in Peritoneal fluid

0.00

-0.00

0.0

1.4

—

162.60

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(3022689) Creatine [Moles/volume] in Urine

0.98

-0.00

1.4

1.5

—

(3046682) IgA [Presence] in Skin by Immunofluorescence

0.00

-0.00

0.0

1.0

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: C3_ENDOCRINE – Malignant neoplasm of endocrine gland

GWS hits: 17

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Malignant neoplasm of endocrine gland

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints